A	O
novel	O
lipopolysaccharide-induced	B-protein
transcription	I-protein
factor	I-protein
regulating	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
gene	O
expression	O
:	O
molecular	O
cloning	O
,	O
sequencing	O
,	O
characterization	O
,	O
and	O
chromosomal	O
assignment	O
.	O

Lipopolysaccharide	O
(	O
LPS	O
)	O
is	O
a	O
potent	O
stimulator	O
of	O
monocytes	B-cell_type
and	O
macrophages	B-cell_type
,	O
causing	O
secretion	O
of	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
and	O
other	O
inflammatory	O
mediators	O
.	O

Given	O
the	O
deleterious	O
effects	O
to	O
the	O
host	O
of	O
TNF-alpha	B-protein
,	O
it	O
has	O
been	O
postulated	O
that	O
TNF-alpha	B-protein
gene	O
expression	O
must	O
be	O
tightly	O
regulated	O
.	O

The	O
nature	O
of	O
the	O
nuclear	B-protein
factor	I-protein
(	O
s	O
)	O
that	O
control	O
TNF-alpha	B-protein
gene	O
transcription	O
in	O
humans	O
remains	O
obscure	O
,	O
although	O
NF-kappaB	B-protein
has	O
been	O
suggested	O
.	O

Our	O
previous	O
studies	O
pertaining	O
to	O
macrophage	O
response	O
to	O
LPS	O
identified	O
a	O
novel	O
DNA-binding	B-protein
domain	I-protein
located	O
from	O
-550	O
to	O
-487	O
in	O
the	O
human	B-DNA
TNF-alpha	I-DNA
promoter	I-DNA
that	O
contains	O
transcriptional	O
activity	O
,	O
but	O
lacks	O
any	O
known	O
NF-kappaB	B-protein
-binding	B-DNA
sites	I-DNA
.	O

We	O
have	O
used	O
this	O
DNA	O
fragment	O
to	O
isolate	O
and	O
purify	O
a	O
60-kDa	B-protein
protein	I-protein
binding	O
to	O
this	O
fragment	O
and	O
obtained	O
its	O
amino-terminal	B-protein
sequence	I-protein
,	O
which	O
was	O
used	O
to	O
design	O
degenerate	B-DNA
probes	I-DNA
to	O
screen	O
a	O
cDNA	O
library	O
from	O
THP-1	B-cell_line
cells	I-cell_line
.	O

A	O
novel	O
cDNA	B-DNA
clone	I-DNA
(	O
1.8	O
kb	O
)	O
was	O
isolated	O
and	O
fully	O
sequenced	O
.	O

Characterization	O
of	O
this	O
cDNA	B-DNA
clone	I-DNA
revealed	O
that	O
its	O
induction	O
was	O
dependent	O
on	O
LPS	O
activation	O
of	O
THP-1	B-cell_line
cells	I-cell_line
;	O
hence	O
,	O
the	O
name	O
LPS-induced	B-protein
TNF-alpha	I-protein
factor	I-protein
(	O
LITAF	B-protein
)	O
.	O

Inhibition	O
of	O
LITAF	B-RNA
mRNA	I-RNA
expression	O
in	O
THP-1	B-cell_line
cells	I-cell_line
resulted	O
in	O
a	O
reduction	O
of	O
TNF-alpha	B-protein
transcripts	O
.	O

In	O
addition	O
,	O
high	O
level	O
of	O
expression	O
of	O
LITAF	B-RNA
mRNA	I-RNA
was	O
observed	O
predominantly	O
in	O
the	O
placenta	O
,	O
peripheral	B-cell_type
blood	I-cell_type
leukocytes	I-cell_type
,	O
lymph	O
nodes	O
,	O
and	O
the	O
spleen	O
.	O

Finally	O
,	O
chromosomal	O
localization	O
using	O
fluorescence	O
in	O
situ	O
hybridization	O
revealed	O
that	O
LITAF	B-protein
mapped	O
to	O
chromosome	B-DNA
16p12-16p13.3	I-DNA
.	O

Together	O
,	O
these	O
findings	O
suggest	O
that	O
LITAF	B-protein
plays	O
an	O
important	O
role	O
in	O
the	O
activation	O
of	O
the	O
human	B-DNA
TNF-alpha	I-DNA
gene	I-DNA
and	O
proposes	O
a	O
new	O
mechanism	O
to	O
control	O
TNF-alpha	B-protein
gene	O
expression	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

96	NULL
,	NULL
pp	NULL
.	NULL

4518-4523	NULL
,	NULL
April	NULL
1999	NULL
Immunology	NULL
A	NULL
novel	NULL
lipopolysaccharide-induced	NULL
transcription	NULL
factor	NULL
regulating	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
expression	NULL
:	NULL
Molecular	NULL
cloning	NULL
,	NULL
sequencing	NULL
,	NULL
characterization	NULL
,	NULL
and	NULL
chromosomal	NULL
assignment	NULL
Fumio	NULL
Myokatr*	NULL
,	NULL
Snoco	NULL
TaKaAsHIBA*	NULL
,	NULL
ROGER	NULL
LEBOT	NULL
,	NULL
AND	NULL
SALOMON	NULL
AmarR	NULL
**	NULL
*Boston	NULL
University	NULL
,	NULL
Department	NULL
of	NULL
Periodontology	NULL
and	NULL
Oral	NULL
Biology	NULL
,	NULL
School	NULL
of	NULL
Dental	NULL
Medicine	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02118	NULL
;	NULL
and	NULL
*Center	NULL
for	NULL
Human	NULL
Genetics	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02118	NULL
Communicated	NULL
by	NULL
Susan	NULL
E.	NULL
Leeman	NULL
,	NULL
Boston	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
,	NULL
February	NULL
18	NULL
,	NULL
1999	NULL
(	NULL
received	NULL
for	NULL
review	NULL
December	NULL
16	NULL
,	NULL
1998	NULL
)	NULL
ABSTRACT	NULL
Lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
is	NULL
a	NULL
potent	NULL
stimula-tor	NULL
of	NULL
monocytes	NULL
and	NULL
macrophages	NULL
,	NULL
causing	NULL
secretion	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
(	NULL
TNF-a	NULL
)	NULL
and	NULL
other	NULL
inflammatory	NULL
mediators	NULL
.	NULL

Given	NULL
the	NULL
deleterious	NULL
effects	NULL
to	NULL
the	NULL
host	NULL
of	NULL
TNF-a	NULL
,	NULL
it	NULL
has	NULL
been	NULL
postulated	NULL
that	NULL
TNF-a	NULL
gene	NULL
expression	NULL
must	NULL
be	NULL
tightly	NULL
regulated	NULL
.	NULL

The	NULL
nature	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
that	NULL
control	NULL
TNF-a	NULL
gene	NULL
transcription	NULL
in	NULL
humans	NULL
remains	NULL
obscure	NULL
,	NULL
although	NULL
NF-KB	NULL
has	NULL
been	NULL
suggested	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
pertaining	NULL
to	NULL
macrophage	NULL
response	NULL
to	NULL
LPS	NULL
identified	NULL
a	NULL
novel	NULL
DNA-binding	NULL
domain	NULL
located	NULL
from	NULL
-550	NULL
to	NULL
-487	NULL
in	NULL
the	NULL
human	NULL
TNF-a	NULL
promoter	NULL
that	NULL
contains	NULL
transcriptional	NULL
activity	NULL
,	NULL
but	NULL
lacks	NULL
any	NULL
known	NULL
NF-KB-binding	NULL
sites	NULL
.	NULL

We	NULL
have	NULL
used	NULL
this	NULL
DNA	NULL
fragment	NULL
to	NULL
isolate	NULL
and	NULL
purify	NULL
a	NULL
60-kDa	NULL
protein	NULL
binding	NULL
to	NULL
this	NULL
fragment	NULL
and	NULL
obtained	NULL
its	NULL
amino-terminal	NULL
sequence	NULL
,	NULL
which	NULL
was	NULL
used	NULL
to	NULL
design	NULL
degenerate	NULL
probes	NULL
to	NULL
screen	NULL
a	NULL
cDNA	NULL
library	NULL
from	NULL
THP-1	NULL
cells	NULL
.	NULL

A	NULL
novel	NULL
cDNA	NULL
clone	NULL
(	NULL
1.8	NULL
kb	NULL
)	NULL
was	NULL
isolated	NULL
and	NULL
fully	NULL
sequenced	NULL
.	NULL

Characterization	NULL
of	NULL
this	NULL
cDNA	NULL
clone	NULL
revealed	NULL
that	NULL
its	NULL
induction	NULL
was	NULL
dependent	NULL
on	NULL
LPS	NULL
activation	NULL
of	NULL
THP-1	NULL
cells	NULL
;	NULL
hence	NULL
,	NULL
the	NULL
name	NULL
LPS-induced	NULL
TNF-alpha	NULL
factor	NULL
(	NULL
LITAF	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
LITAF	NULL
mRNA	NULL
expression	NULL
in	NULL
THP-1	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
reduction	NULL
of	NULL
TNF-a	NULL
transcripts	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
high	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
LITAF	NULL
mRNA	NULL
was	NULL
observed	NULL
predominantly	NULL
in	NULL
the	NULL
placenta	NULL
,	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
,	NULL
lymph	NULL
nodes	NULL
,	NULL
and	NULL
the	NULL
spleen	NULL
.	NULL

Finally	NULL
,	NULL
chromosomal	NULL
localization	NULL
using	NULL
fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
revealed	NULL
that	NULL
LITAF	NULL
mapped	NULL
to	NULL
chromosome	NULL
16p12-16p13.3	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
LITAF	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
gene	NULL
and	NULL
proposes	NULL
a	NULL
new	NULL
mechanism	NULL
to	NULL
control	NULL
TNF-a	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
innate	NULL
host	NULL
response	NULL
to	NULL
bacterial	NULL
pathogens	NULL
is	NULL
characterized	NULL
by	NULL
an	NULL
immediate	NULL
release	NULL
of	NULL
biologically	NULL
active	NULL
compounds	NULL
,	NULL
including	NULL
monokines	NULL
and	NULL
cytokines	NULL
.	NULL

These	NULL
proinflammatory	NULL
mol-ecules	NULL
,	NULL
which	NULL
are	NULL
intended	NULL
to	NULL
enable	NULL
the	NULL
host	NULL
to	NULL
eliminate	NULL
the	NULL
pathogen	NULL
,	NULL
may	NULL
adversely	NULL
affect	NULL
the	NULL
host	NULL
.	NULL

Endotoxins	NULL
,	NULL
produced	NULL
from	NULL
the	NULL
outer	NULL
membrane	NULL
of	NULL
Gram-negative	NULL
bacteria	NULL
,	NULL
and	NULL
exo-toxins	NULL
,	NULL
released	NULL
from	NULL
the	NULL
cell	NULL
wall	NULL
of	NULL
Gram-positive	NULL
bacteria	NULL
,	NULL
are	NULL
known	NULL
to	NULL
be	NULL
potent	NULL
inducers	NULL
of	NULL
the	NULL
inflammatory	NULL
response	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
extracted	NULL
from	NULL
the	NULL
outer	NULL
membrane	NULL
of	NULL
Gram-negative	NULL
bacteria	NULL
,	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
principal	NULL
endotoxic	NULL
component	NULL
.	NULL

It	NULL
is	NULL
well	NULL
known	NULL
that	NULL
LPS	NULL
is	NULL
one	NULL
of	NULL
the	NULL
most	NULL
potent	NULL
stimulators	NULL
of	NULL
monocytes	NULL
and	NULL
macrophages	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
secretion	NULL
of	NULL
nitrogen	NULL
intermediates	NULL
,	NULL
prostaglandins	NULL
,	NULL
and	NULL
cytokines	NULL
.	NULL

Secretion	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
Â«	NULL
(	NULL
TNF-a	NULL
@	NULL
)	NULL
,	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-12	NULL
,	NULL
demonstrated	NULL
both	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
,	NULL
leads	NULL
to	NULL
rapid	NULL
induction	NULL
and	NULL
amplification	NULL
of	NULL
the	NULL
host	NULL
response	NULL
to	NULL
infection	NULL
(	NULL
5-8	NULL
)	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
other	NULL
cells	NULL
are	NULL
induced	NULL
to	NULL
produce	NULL
large	NULL
quantities	NULL
of	NULL
IL-1	NULL
,	NULL
TNF	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IL-8	NULL
,	NULL
which	NULL
mediate	NULL
the	NULL
induction	NULL
of	NULL
fever	NULL
(	NULL
6	NULL
,	NULL
7	NULL
,	NULL
9	NULL
)	NULL
,	NULL
synthesis	NULL
of	NULL
acute-phase	NULL
proteins	NULL
(	NULL
10	NULL
)	NULL
,	NULL
release	NULL
of	NULL
collagenase	NULL
(	NULL
8	NULL
)	NULL
,	NULL
and	NULL
synthesis	NULL
of	NULL
prostaglandin	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
acute	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Â§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
www.pnas.org	NULL
.	NULL

4518	NULL
situations	NULL
,	NULL
the	NULL
pathogen	NULL
often	NULL
is	NULL
eliminated	NULL
,	NULL
with	NULL
resolution	NULL
of	NULL
inflammation	NULL
and	NULL
minimal	NULL
tissue	NULL
damage	NULL
.	NULL

However	NULL
,	NULL
failure	NULL
to	NULL
control	NULL
the	NULL
pathogen	NULL
often	NULL
leads	NULL
to	NULL
a	NULL
state	NULL
of	NULL
metabolic	NULL
anarchy	NULL
in	NULL
which	NULL
the	NULL
inflammatory	NULL
response	NULL
is	NULL
not	NULL
controlled	NULL
and	NULL
significant	NULL
tissue	NULL
damage	NULL
results	NULL
.	NULL

Although	NULL
the	NULL
inflammatory	NULL
response	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
secreted	NULL
factors	NULL
,	NULL
the	NULL
cytotoxic	NULL
effects	NULL
of	NULL
LPS	NULL
have	NULL
been	NULL
ascribed	NULL
to	NULL
TNF-a	NULL
activity	NULL
(	NULL
4	NULL
,	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

TNF-a	NULL
is	NULL
a	NULL
pleiotropic	NULL
cytokine	NULL
and	NULL
may	NULL
benefit	NULL
the	NULL
host	NULL
or	NULL
exert	NULL
detrimental	NULL
effects	NULL
on	NULL
the	NULL
host	NULL
(	NULL
14-16	NULL
)	NULL
.	NULL

TNF-a	NULL
helps	NULL
prevent	NULL
cancer	NULL
(	NULL
17	NULL
)	NULL
,	NULL
protects	NULL
against	NULL
infection	NULL
(	NULL
18-21	NULL
)	NULL
,	NULL
promotes	NULL
tissue	NULL
remodeling	NULL
(	NULL
22	NULL
)	NULL
,	NULL
and	NULL
activates	NULL
inflammatory	NULL
responses	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
TNF-a	NULL
mediates	NULL
septic	NULL
shock	NULL
in	NULL
chronic	NULL
infections	NULL
(	NULL
4	NULL
,	NULL
24	NULL
,	NULL
25	NULL
)	NULL
,	NULL
is	NULL
responsible	NULL
for	NULL
cachexia	NULL
in	NULL
cancer	NULL
patients	NULL
(	NULL
26	NULL
)	NULL
,	NULL
causes	NULL
inflammation	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
patients	NULL
(	NULL
27	NULL
,	NULL
28	NULL
)	NULL
,	NULL
and	NULL
activates	NULL
HIV	NULL
(	NULL
29-32	NULL
)	NULL
.	NULL

The	NULL
pleiotropic	NULL
effects	NULL
of	NULL
TNF-a	NULL
are	NULL
dose-dependent	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
perceived	NULL
need	NULL
to	NULL
control	NULL
TNF-a	NULL
production	NULL
has	NULL
raised	NULL
interest	NULL
into	NULL
the	NULL
understanding	NULL
of	NULL
the	NULL
mechanisms	NULL
that	NULL
modulate	NULL
TNF-a	NULL
gene	NULL
expression	NULL
.	NULL

It	NULL
is	NULL
well	NULL
known	NULL
that	NULL
gene	NULL
transcription	NULL
is	NULL
controlled	NULL
by	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
several	NULL
groups	NULL
have	NULL
examined	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
TNF-a	NULL
by	NULL
various	NULL
in-ducers	NULL
,	NULL
such	NULL
as	NULL
virus	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
(	NULL
35-45	NULL
)	NULL
.	NULL

The	NULL
human	NULL
TNF-a	NULL
promoter	NULL
contains	NULL
motifs	NULL
that	NULL
resemble	NULL
sites	NULL
;	NULL
however	NULL
,	NULL
controversy	NULL
exists	NULL
as	NULL
to	NULL
the	NULL
involvement	NULL
of	NULL
NF-kB	NULL
in	NULL
TNF-a	NULL
gene	NULL
regulation	NULL
.	NULL

These	NULL
sequences	NULL
do	NULL
not	NULL
seem	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
virus	NULL
or	NULL
LPS	NULL
induction	NULL
,	NULL
nor	NULL
do	NULL
they	NULL
appear	NULL
to	NULL
be	NULL
able	NULL
to	NULL
stimulate	NULL
virus	NULL
or	NULL
LPS	NULL
induction	NULL
alone	NULL
(	NULL
35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
NF-kB	NULL
is	NULL
an	NULL
important	NULL
factor	NULL
in	NULL
TNF-a	NULL
gene	NULL
transcription	NULL
in	NULL
LPS-challenged	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

NF-kB-binding	NULL
motifs	NULL
are	NULL
found	NULL
in	NULL
the	NULL
human	NULL
TNF-a	NULL
promoter	NULL
region	NULL
(	NULL
46	NULL
,	NULL
47	NULL
)	NULL
and	NULL
were	NULL
shown	NULL
to	NULL
translocate	NULL
into	NULL
the	NULL
nuclei	NULL
of	NULL
LPS-stimulated	NULL
monocytes	NULL
(	NULL
36	NULL
,	NULL
48	NULL
,	NULL
49	NULL
)	NULL
.	NULL

In	NULL
mice	NULL
,	NULL
mutation	NULL
(	NULL
s	NULL
)	NULL
or	NULL
deletion	NULL
(	NULL
s	NULL
)	NULL
of	NULL
NF-	NULL
Â«	NULL
B-binding	NULL
motifs	NULL
on	NULL
the	NULL
TNF-a	NULL
promoter	NULL
failed	NULL
to	NULL
show	NULL
reporter	NULL
gene	NULL
activation	NULL
in	NULL
transfected	NULL
cells	NULL
(	NULL
37	NULL
,	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
humans	NULL
,	NULL
TNF-	NULL
Â«	NULL
promoter	NULL
activity	NULL
in	NULL
transfected	NULL
cell	NULL
lines	NULL
was	NULL
found	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
the	NULL
NF-	NULL
Â«	NULL
B-binding	NULL
motifs	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Drouet	NULL
et	NULL
al	NULL
.	NULL

(	NULL
37	NULL
)	NULL
offered	NULL
an	NULL
explanation	NULL
for	NULL
these	NULL
conflicting	NULL
data	NULL
,	NULL
suggesting	NULL
that	NULL
enough	NULL
NF-KB	NULL
is	NULL
constitutively	NULL
expressed	NULL
to	NULL
sustain	NULL
high-level	NULL
baseline	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
gene	NULL
(	NULL
52	NULL
)	NULL
compared	NULL
with	NULL
the	NULL
mouse	NULL
.	NULL

Nonetheless	NULL
,	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
LPS-induced	NULL
TNF-a	NULL
gene	NULL
expression	NULL
in	NULL
humans	NULL
remains	NULL
unknown	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
pertaining	NULL
to	NULL
macrophage	NULL
response	NULL
to	NULL
LPS	NULL
have	NULL
identified	NULL
a	NULL
DNA	NULL
sequence	NULL
domain	NULL
located	NULL
from	NULL
-550	NULL
to	NULL
-487	NULL
in	NULL
the	NULL
human	NULL
TNF-a	NULL
promoter	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Using	NULL
electro-	NULL
Abbreviations	NULL
:	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-	NULL
myristate	NULL
13-acetate	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
LITAF	NULL
,	NULL
LPS-induced	NULL
TNF-alpha	NULL
factor	NULL
;	NULL
FISH	NULL
,	NULL
fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
;	NULL
UTR	NULL
,	NULL
untranslated	NULL
region	NULL
.	NULL

Data	NULL
deposition	NULL
:	NULL
The	NULL
sequence	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
deposited	NULL
in	NULL
the	NULL
GenBank	NULL
database	NULL
(	NULL
accession	NULL
no	NULL
.	NULL

U77396	NULL
)	NULL
.	NULL

*To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
:	NULL
Boston	NULL
University	NULL
,	NULL
100	NULL
East	NULL
Newton	NULL
,	NULL
G05	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02118.	NULL
e-mail	NULL
:	NULL
samar	NULL
@	NULL
bu.edu	NULL
.	NULL

Immunology	NULL
:	NULL
Myokai	NULL
et	NULL
al	NULL
.	NULL

phoretic	NULL
mobility-shift	NULL
assays	NULL
and	NULL
selective	NULL
mutations	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
a	NULL
64-bp	NULL
fragment	NULL
located	NULL
within	NULL
this	NULL
region	NULL
can	NULL
bind	NULL
unknown	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
and	NULL
this	NULL
binding	NULL
is	NULL
responsible	NULL
for	NULL
TNF-a	NULL
transcriptional	NULL
activity	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
this	NULL
fragment	NULL
revealed	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
potential	NULL
NF-	NULL
Â«	NULL
B-binding	NULL
sites	NULL
(	NULL
53	NULL
)	NULL
.	NULL

These	NULL
intriguing	NULL
results	NULL
suggested	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
novel	NULL
cis-acting	NULL
regulatory	NULL
protein	NULL
,	NULL
other	NULL
than	NULL
NF-KB	NULL
,	NULL
that	NULL
is	NULL
necessary	NULL
for	NULL
human	NULL
TNF-a	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
an	NULL
effort	NULL
to	NULL
further	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
LPS-induced	NULL
TNF-a	NULL
gene	NULL
regulation	NULL
,	NULL
we	NULL
used	NULL
this	NULL
64-bp	NULL
fragment	NULL
to	NULL
isolate	NULL
the	NULL
purported	NULL
native	NULL
protein	NULL
.	NULL

Its	NULL
amino-terminal	NULL
sequence	NULL
was	NULL
obtained	NULL
and	NULL
used	NULL
to	NULL
design	NULL
PCR	NULL
primers	NULL
to	NULL
screen	NULL
a	NULL
THP-1	NULL
cDNA	NULL
library	NULL
.	NULL

Using	NULL
these	NULL
probes	NULL
,	NULL
we	NULL
isolated	NULL
a	NULL
novel	NULL
full-length	NULL
cDNA	NULL
(	NULL
1.8	NULL
kb	NULL
)	NULL
with	NULL
a	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
ORF	NULL
encoding	NULL
229	NULL
aa	NULL
.	NULL

Characterization	NULL
of	NULL
this	NULL
new	NULL
gene	NULL
revealed	NULL
that	NULL
its	NULL
expression	NULL
resulted	NULL
from	NULL
LPS	NULL
stimulation	NULL
of	NULL
THP	NULL
cells	NULL
;	NULL
hence	NULL
,	NULL
the	NULL
name	NULL
LPS-induced	NULL
TNF-alpha	NULL
factor	NULL
(	NULL
LITAF	NULL
)	NULL
.	NULL

We	NULL
investigated	NULL
tissue	NULL
distribution	NULL
of	NULL
the	NULL
LITAF	NULL
gene	NULL
and	NULL
found	NULL
transcripts	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
human	NULL
adult	NULL
tissues	NULL
.	NULL

Northern	NULL
blot	NULL
hybridization	NULL
revealed	NULL
a	NULL
high	NULL
level	NULL
of	NULL
expression	NULL
in	NULL
the	NULL
placenta	NULL
,	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
,	NULL
lymph	NULL
nodes	NULL
,	NULL
and	NULL
the	NULL
spleen	NULL
.	NULL

Inhibition	NULL
of	NULL
LITAF	NULL
mRNA	NULL
translation	NULL
using	NULL
antisense	NULL
DNA	NULL
in	NULL
naive	NULL
THP-1	NULL
cells	NULL
or	NULL
those	NULL
exposed	NULL
to	NULL
LPS	NULL
resulted	NULL
in	NULL
a	NULL
reduction	NULL
of	NULL
TNF-a	NULL
transcripts	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
chromosomal	NULL
localization	NULL
using	NULL
fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
(	NULL
FISH	NULL
)	NULL
revealed	NULL
that	NULL
LITAF	NULL
mapped	NULL
to	NULL
chromosome	NULL
16p12-16p13.3	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
LITAF	NULL
gene	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
human	NULL
TNF-a	NULL
gene	NULL
activation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture	NULL
.	NULL

The	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
,	NULL
THP-1	NULL
,	NULL
was	NULL
maintained	NULL
in	NULL
complete	NULL
RPMI	NULL
[	NULL
C-RPMI	NULL
;	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
L-glutamine/25	NULL
mM	NULL
Hepes/100	NULL
units/ml	NULL
of	NULL
penicillin/100	NULL
mg/ml	NULL
of	NULL
streptomycin/10	NULL
%	NULL
FBS	NULL
(	NULL
all	NULL
from	NULL
GIBCO	NULL
)	NULL
]	NULL
.	NULL

LPS	NULL
-free	NULL
tissue	NULL
culture	NULL
reagents	NULL
were	NULL
used	NULL
for	NULL
all	NULL
experiments	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
from	NULL
Cultured	NULL
THP-1	NULL
Cells	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
induced	NULL
to	NULL
maturation	NULL
by	NULL
incubation	NULL
in	NULL
200	NULL
nM	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
20	NULL
hr	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
100	NULL
ng/ml	NULL
of	NULL
Porphyromonas	NULL
gingivalis	NULL
LPS	NULL
(	NULL
54	NULL
)	NULL
for	NULL
2	NULL
hr	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
our	NULL
previous	NULL
work	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Preparation	NULL
of	NULL
DNA	NULL
Affinity	NULL
Beads	NULL
.	NULL

The	NULL
64-bp	NULL
initiator	NULL
element	NULL
located	NULL
from	NULL
-550	NULL
to	NULL
-487	NULL
in	NULL
the	NULL
human	NULL
TNF-a	NULL
promoter	NULL
(	NULL
55	NULL
)	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
.	NULL

The	NULL
PCR	NULL
mixture	NULL
(	NULL
50	NULL
ml	NULL
)	NULL
was	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
55	NULL
)	NULL
.	NULL

The	NULL
human	NULL
TNF-a	NULL
promoter	NULL
(	NULL
55	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
template	NULL
for	NULL
the	NULL
PCR	NULL
.	NULL

We	NULL
used	NULL
the	NULL
sequence	NULL
5-TGAGGCCTCAAGCTGCCACCA-3	NULL
'	NULL
for	NULL
the	NULL
forward	NULL
primer	NULL
sequence	NULL
and	NULL
5'-XTGAGGCCTGTGTTT-GGGTCTG-3	NULL
'	NULL
for	NULL
the	NULL
reverse	NULL
sequence	NULL
(	NULL
X	NULL
=	NULL
5	NULL
'	NULL
biotin	NULL
)	NULL
.	NULL

The	NULL
cycling	NULL
parameters	NULL
(	NULL
30	NULL
cycles	NULL
)	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
an	NULL
initial	NULL
dena-turation	NULL
at	NULL
94Â°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
annealing	NULL
at	NULL
55Â°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
elongation	NULL
at	NULL
72Â°C	NULL
for	NULL
1	NULL
min	NULL
.	NULL

The	NULL
last	NULL
cycle	NULL
had	NULL
an	NULL
additional	NULL
elongation	NULL
time	NULL
of	NULL
7	NULL
min	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
agarose	NULL
gel	NULL
,	NULL
and	NULL
the	NULL
64-bp	NULL
DNA	NULL
bands	NULL
were	NULL
cut	NULL
from	NULL
the	NULL
gel	NULL
.	NULL

The	NULL
unincorporated	NULL
biotinylated	NULL
primers	NULL
were	NULL
removed	NULL
by	NULL
using	NULL
the	NULL
QIAEX	NULL
II	NULL
Gel	NULL
Extraction	NULL
Kit	NULL
(	NULL
Qiagen	NULL
)	NULL
.	NULL

The	NULL
biotinylated	NULL
DNA	NULL
was	NULL
desalted	NULL
and	NULL
dissolved	NULL
in	NULL
TrisHCI/EDTA	NULL
(	NULL
2	NULL
mg/m	NULL
!	NULL
)	NULL

and	NULL
then	NULL
used	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
DNA	NULL
affinity	NULL
beads	NULL
.	NULL

Immobilization	NULL
of	NULL
labeled	NULL
DNA	NULL
to	NULL
Dynabeads	NULL
M-280	NULL
streptavidin	NULL
(	NULL
10	NULL
mg/ml	NULL
;	NULL
Dynal	NULL
,	NULL
Great	NULL
Neck	NULL
,	NULL
NY	NULL
)	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Gabrielsen	NULL
and	NULL
Huet	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
a	NULL
suspension	NULL
of	NULL
beads	NULL
was	NULL
coupled	NULL
with	NULL
the	NULL
labeled	NULL
DNA	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
affinity	NULL
beads	NULL
were	NULL
washed	NULL
to	NULL
remove	NULL
unbound	NULL
DNA	NULL
and	NULL
then	NULL
used	NULL
for	NULL
purification	NULL
of	NULL
DNA-binding	NULL
protein	NULL
.	NULL

Purification	NULL
of	NULL
DNA-Binding	NULL
Protein	NULL
Using	NULL
Affinity	NULL
Beads	NULL
.	NULL

Purification	NULL
of	NULL
the	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
beads	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
beads	NULL
in	NULL
binding	NULL
buffer	NULL
containing	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
washing	NULL
(	NULL
twice	NULL
)	NULL
,	NULL
the	NULL
DNA	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
4519	NULL
binding	NULL
protein	NULL
was	NULL
eluted	NULL
,	NULL
desalted	NULL
,	NULL
and	NULL
then	NULL
used	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
DNA-Binding	NULL
Protein	NULL
and	NULL
Sequence	NULL
Analysis	NULL
.	NULL

The	NULL
eluted	NULL
protein	NULL
sample	NULL
was	NULL
separated	NULL
on	NULL
12	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
53	NULL
)	NULL
.	NULL

The	NULL
resolved	NULL
proteins	NULL
(	NULL
approximately	NULL
2	NULL
%	NULL
of	NULL
the	NULL
protein	NULL
of	NULL
the	NULL
total	NULL
protein	NULL
)	NULL
were	NULL
electroblotted	NULL
onto	NULL
a	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
as	NULL
described	NULL
by	NULL
Matsudaira	NULL
(	NULL
57	NULL
)	NULL
and	NULL
stained	NULL
with	NULL
Coomassie	NULL
blue	NULL
.	NULL

A	NULL
predominant-stained	NULL
protein	NULL
band	NULL
with	NULL
an	NULL
apparent	NULL
molecular	NULL
mass	NULL
of	NULL
60	NULL
kDa	NULL
was	NULL
excised	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
trypsin	NULL
(	NULL
58	NULL
)	NULL
,	NULL
the	NULL
resultant	NULL
peptides	NULL
were	NULL
separated	NULL
by	NULL
HPLC	NULL
on	NULL
a	NULL
C18	NULL
column	NULL
with	NULL
a	NULL
0-100	NULL
%	NULL
acetonitrile	NULL
gradient	NULL
containing	NULL
0.01	NULL
%	NULL
trifluoroacetic	NULL
acid	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Fractions	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
a	NULL
number	NULL
of	NULL
peptides	NULL
were	NULL
sequenced	NULL
by	NULL
established	NULL
methods	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
57	NULL
)	NULL
.	NULL

All	NULL
peptide	NULL
sequences	NULL
were	NULL
found	NULL
in	NULL
the	NULL
isolated	NULL
cDNA	NULL
clone	NULL
.	NULL

Degenerate	NULL
oligonucleotides	NULL
(	NULL
16-mer	NULL
)	NULL
corresponding	NULL
to	NULL
either	NULL
end	NULL
of	NULL
peptide	NULL
1	NULL
,	NULL
M-S-V-P-G-P-Y-Q-A-A-T-G	NULL
,	NULL
were	NULL
used	NULL
for	NULL
PCR	NULL
by	NULL
using	NULL
the	NULL
LPS-induced	NULL
THP-1	NULL
cDNA	NULL
as	NULL
a	NULL
template	NULL
to	NULL
obtain	NULL
a	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
exact	NULL
nucleotide	NULL
sequences	NULL
encoding	NULL
the	NULL
middle	NULL
part	NULL
of	NULL
this	NULL
peptide	NULL
.	NULL

PCR	NULL
products	NULL
resolved	NULL
in	NULL
an	NULL
8	NULL
%	NULL
acrylamide	NULL
gel	NULL
were	NULL
eluted	NULL
by	NULL
using	NULL
the	NULL
QIAEX	NULL
II	NULL
Gel	NULL
Extraction	NULL
Kit	NULL
(	NULL
Qiagen	NULL
)	NULL
and	NULL
subcloned	NULL
into	NULL
a	NULL
PCR	NULL
II	NULL
vector	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

Sequencing	NULL
verified	NULL
the	NULL
fidelity	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
.	NULL

Screening	NULL
the	NULL
cDNA	NULL
Library	NULL
.	NULL

An	NULL
LPS-stimulated	NULL
,	NULL
PMA-induced	NULL
,	NULL
custom-made	NULL
human	NULL
THP-1	NULL
Uni-ZAP	NULL
XR	NULL
cDNA	NULL
library	NULL
(	NULL
Stratagene	NULL
)	NULL
was	NULL
screened	NULL
by	NULL
using	NULL
this	NULL
PCR	NULL
probe	NULL
,	NULL
and	NULL
nine	NULL
positive	NULL
clones	NULL
containing	NULL
0.8-	NULL
to	NULL
1.8-kb	NULL
inserts	NULL
were	NULL
obtained	NULL
after	NULL
screening	NULL
5	NULL
X	NULL
10Â°	NULL
colonies	NULL
.	NULL

The	NULL
longest	NULL
cDNA	NULL
insert	NULL
(	NULL
1.8	NULL
kb	NULL
)	NULL
was	NULL
chosen	NULL
for	NULL
complete	NULL
sequencing	NULL
after	NULL
the	NULL
dideoxynucleotide	NULL
chain-termination	NULL
method	NULL
by	NULL
using	NULL
a	NULL
373A	NULL
sequencer	NULL
(	NULL
Applied	NULL
Biosystems	NULL
)	NULL
.	NULL

The	NULL
BLAST	NULL
program	NULL
was	NULL
used	NULL
to	NULL
search	NULL
the	NULL
database	NULL
through	NULL
the	NULL
National	NULL
Center	NULL
for	NULL
Biotechnology	NULL
Information	NULL
.	NULL

The	NULL
PILEUP	NULL
and	NULL
PRETTYBOX	NULL
programs	NULL
were	NULL
used	NULL
for	NULL
sequence	NULL
alignments	NULL
and	NULL
comparisons	NULL
.	NULL

The	NULL
FASTA	NULL
program	NULL
was	NULL
used	NULL
for	NULL
calculating	NULL
the	NULL
protein	NULL
identities	NULL
.	NULL

All	NULL
these	NULL
computer	NULL
programs	NULL
were	NULL
from	NULL
the	NULL
Wisconsin	NULL
Genetics	NULL
Computer	NULL
Group	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
SIGSCAN	NULL
program	NULL
was	NULL
used	NULL
to	NULL
search	NULL
the	NULL
Transcription	NULL
Factor	NULL
Database	NULL
(	NULL
TFD	NULL
)	NULL
through	NULL
the	NULL
BIMaASs	NULL
program	NULL
of	NULL
the	NULL
Advanced	NULL
Biosciences	NULL
Computing	NULL
Systems	NULL
maintained	NULL
at	NULL
the	NULL
University	NULL
of	NULL
Minnesota	NULL
.	NULL

Detection	NULL
of	NULL
LITAF	NULL
Gene	NULL
Transcripts	NULL
.	NULL

The	NULL
transcripts	NULL
for	NULL
the	NULL
new	NULL
gene	NULL
were	NULL
detected	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
in	NULL
cultured	NULL
THP-1	NULL
cells	NULL
and	NULL
other	NULL
human	NULL
tissues	NULL
.	NULL

First	NULL
,	NULL
THP-1	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10Â°	NULL
)	NULL
were	NULL
induced	NULL
to	NULL
maturation	NULL
by	NULL
incubation	NULL
in	NULL
200	NULL
nM	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
20	NULL
hr	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
100	NULL
ng/ml	NULL
of	NULL
P.	NULL
gingivalis	NULL
LPS	NULL
(	NULL
54	NULL
)	NULL
for	NULL
2	NULL
hr	NULL
.	NULL

Noninduced	NULL
THP-1	NULL
cells	NULL
also	NULL
were	NULL
cultured	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
collected	NULL
by	NULL
using	NULL
RNA	NULL
STAT-60	NULL
(	NULL
Tel-Test	NULL
,	NULL
Friendswood	NULL
,	NULL
TX	NULL
)	NULL
by	NULL
the	NULL
method	NULL
described	NULL
in	NULL
the	NULL
instruction	NULL
manual	NULL
,	NULL
and	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
RNA	NULL
(	NULL
mRNA	NULL
)	NULL
was	NULL
recovered	NULL
by	NULL
using	NULL
the	NULL
Oligotex	NULL
mRNA	NULL
Kit	NULL
(	NULL
Qiagen	NULL
)	NULL
.	NULL

mRNA	NULL
was	NULL
size-fractionated	NULL
on	NULL
denaturing	NULL
formaldehyde-agarose	NULL
gel	NULL
(	NULL
1.1	NULL
%	NULL
)	NULL
and	NULL
transferred	NULL
onto	NULL
a	NULL
Hybond-N*	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
filters	NULL
with	NULL
mRNA	NULL
from	NULL
several	NULL
different	NULL
human	NULL
tissues	NULL
were	NULL
obtained	NULL
from	NULL
CLON-TECH	NULL
.	NULL

These	NULL
filters	NULL
were	NULL
hybridized	NULL
with	NULL
an	NULL
Â°S-labeled	NULL
cRNA	NULL
probe	NULL
at	NULL
60Â°C	NULL
overnight	NULL
in	NULL
50	NULL
%	NULL
formamide/5x	NULL
SSC/5	NULL
%	NULL
Den-hardt	NULL
's	NULL
solution/0.1	NULL
%	NULL
SDS/50	NULL
mM	NULL
sodium	NULL
phosphate	NULL
,	NULL
pH	NULL
6.9/	NULL
heat-denatured	NULL
salmon	NULL
sperm	NULL
DNA	NULL
.	NULL

The	NULL
filters	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
0.1	NULL
%	NULL
SSC/0.1	NULL
%	NULL
SDS	NULL
at	NULL
68Â°C	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
autoradiographed	NULL
with	NULL
BIOMAX	NULL
MBR	NULL
film	NULL
(	NULL
Kodak	NULL
)	NULL
.	NULL

The	NULL
511	NULL
bp	NULL
of	NULL
the	NULL
Hincll-Apal	NULL
cDNA	NULL
fragment	NULL
from	NULL
the	NULL
coding	NULL
sequence	NULL
in	NULL
the	NULL
new	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
pGEMT7Zf	NULL
(	NULL
+	NULL
)	NULL
(	NULL
Pro-mega	NULL
)	NULL
.	NULL

The	NULL
antisense	NULL
and	NULL
sense	NULL
riboprobes	NULL
were	NULL
prepared	NULL
from	NULL
this	NULL
plasmid	NULL
and	NULL
labeled	NULL
with	NULL
[	NULL
Â°Â°SJUTP	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
59	NULL
)	NULL
.	NULL

These	NULL
probes	NULL
were	NULL
used	NULL
for	NULL
Northern	NULL
hybridizations	NULL
.	NULL

Antisense	NULL
and	NULL
Sense	NULL
Construct	NULL
.	NULL

Eukaryotic	NULL
expression	NULL
vectors	NULL
(	NULL
pRe/CMV	NULL
;	NULL
Invitrogen	NULL
)	NULL
were	NULL
constructed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
60	NULL
,	NULL
61	NULL
)	NULL
with	NULL
slight	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
LITAF	NULL
cDNA	NULL
4520	NULL
Immunology	NULL
:	NULL
Myokai	NULL
et	NULL
al	NULL
.	NULL

Eco	NULL
RI	NULL
\a	NULL
1	NULL
[	NULL
--	NULL
Pst	NULL
!	NULL

[	NULL
--	NULL
Hinc	NULL
I	NULL
|-	NULL
PstI	NULL
PstI	NULL
Sac	NULL
I	NULL
|-	NULL
Apa	NULL
[	NULL
-	NULL
Sac	NULL
1773	NULL
I	NULL
I	NULL
5	NULL
!	NULL

UTR	NULL
_	NULL
AUG	NULL
234	NULL
-	NULL
Coding	NULL
region	NULL
UAG	NULL
918	NULL
3Â°	NULL
UTR	NULL
AS	NULL
5	NULL
``	NULL
SE	NULL
Â¥	NULL
Fig	NULL
.	NULL

1.	NULL
cDNA	NULL
cloning	NULL
of	NULL
LITAF	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Physical	NULL
map	NULL
of	NULL
the	NULL
LITAF	NULL
cDNA	NULL
isolated	NULL
.	NULL

The	NULL
dark	NULL
,	NULL
thicker	NULL
line	NULL
denotes	NULL
the	NULL
ORF	NULL
(	NULL
from	NULL
AUG	NULL
234	NULL
to	NULL
UAG	NULL
918	NULL
)	NULL
in	NULL
LITAF	NULL
.	NULL

Restriction	NULL
sites	NULL
for	NULL
EcoRI	NULL
,	NULL
HinclI	NULL
,	NULL
Psfl	NULL
,	NULL
Sacl	NULL
,	NULL
and	NULL
Apal	NULL
are	NULL
shown	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
antisense	NULL
RNA	NULL
represented	NULL
as	NULL
ASS	NULL
was	NULL
designed	NULL
to	NULL
be	NULL
complementary	NULL
to	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
LITAF	NULL
mRNA	NULL
between	NULL
the	NULL
restriction	NULL
sites	NULL
(	NULL
EcoRI	NULL
and	NULL
HinclI	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
full-length	NULL
LITAF	NULL
was	NULL
used	NULL
as	NULL
sense	NULL
RNA	NULL
for	NULL
overexpression	NULL
of	NULL
LITAF	NULL
RNA	NULL
and	NULL
is	NULL
shown	NULL
as	NULL
SE	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Schematic	NULL
structure	NULL
of	NULL
antisense	NULL
or	NULL
sense	NULL
constructs	NULL
inserted	NULL
downstream	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
.	NULL

fragments	NULL
(	NULL
indicated	NULL
below	NULL
and	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
were	NULL
placed	NULL
in	NULL
either	NULL
an	NULL
antisense	NULL
or	NULL
a	NULL
sense	NULL
orientation	NULL
downstream	NULL
of	NULL
the	NULL
human	NULL
cytomegalovirus	NULL
promoter	NULL
element	NULL
as	NULL
the	NULL
first	NULL
ORF	NULL
.	NULL

The	NULL
vector	NULL
contained	NULL
a	NULL
neo-resistance	NULL
gene	NULL
for	NULL
selection	NULL
of	NULL
stable	NULL
transfec-tants	NULL
.	NULL

Plasmid	NULL
constructions	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
ASS5	NULL
'	NULL
,	NULL
antisense	NULL
cDNA	NULL
corresponding	NULL
to	NULL
a	NULL
320-bp	NULL
fragment	NULL
that	NULL
covered	NULL
the	NULL
5	NULL
'	NULL
untranslated	NULL
region	NULL
(	NULL
UTR	NULL
)	NULL
and	NULL
the	NULL
AUG	NULL
start	NULL
codon	NULL
;	NULL
SE	NULL
,	NULL
sense	NULL
full-length	NULL
of	NULL
cDNA	NULL
;	NULL
and	NULL
CON	NULL
,	NULL
control	NULL
vector	NULL
without	NULL
insert	NULL
.	NULL

These	NULL
constructions	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

All	NULL
plasmids	NULL
were	NULL
prepared	NULL
by	NULL
using	NULL
Qiagen	NULL
Plasmid	NULL
Midiprep	NULL
Kits	NULL
.	NULL

Stable	NULL
Transfection	NULL
.	NULL

THP-1	NULL
cells	NULL
(	NULL
5	NULL
xX	NULL
10Â°/cuvette	NULL
)	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
(	NULL
Gene	NULL
Pulser	NULL
;	NULL
Bio-Rad	NULL
)	NULL
with	NULL
20	NULL
mg	NULL
of	NULL
recombinant	NULL
plasmid	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Mock	NULL
cells	NULL
were	NULL
transfected	NULL
similarly	NULL
with	NULL
a	NULL
control	NULL
vector	NULL
(	NULL
pReCON	NULL
)	NULL
.	NULL

Two	NULL
days	NULL
later	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
C-RPMI	NULL
containing	NULL
0.8	NULL
mg/ml	NULL
of	NULL
G418	NULL
(	NULL
Geneticin	NULL
;	NULL
GIBCO	NULL
)	NULL
.	NULL

This	NULL
medium	NULL
was	NULL
changed	NULL
every	NULL
3	NULL
days	NULL
.	NULL

The	NULL
surviving	NULL
cells	NULL
were	NULL
used	NULL
for	NULL
further	NULL
experimentation	NULL
.	NULL

Monitoring	NULL
of	NULL
Exogenous	NULL
mRNA	NULL
Expression	NULL
.	NULL

Success	NULL
of	NULL
stable	NULL
transformation	NULL
was	NULL
confirmed	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
with	NULL
antisense	NULL
and	NULL
sense	NULL
riboprobes	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
recovered	NULL
from	NULL
transfected	NULL
cells	NULL
(	NULL
2	NULL
%	NULL
10Â°	NULL
)	NULL
and	NULL
used	NULL
for	NULL
Northern	NULL
blot	NULL
analysis	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
that	NULL
described	NULL
previously	NULL
.	NULL

The	NULL
707	NULL
bp	NULL
of	NULL
the	NULL
EcoRI-SacI	NULL
cDNA	NULL
fragment	NULL
,	NULL
which	NULL
contained	NULL
a	NULL
5	NULL
UTR	NULL
and	NULL
a	NULL
coding	NULL
sequence	NULL
for	NULL
the	NULL
new	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
was	NULL
subcloned	NULL
into	NULL
pBluescript	NULL
SKII	NULL
(	NULL
-	NULL
)	NULL
.	NULL

The	NULL
S-labeled	NULL
riboprobes	NULL
for	NULL
hybridization	NULL
were	NULL
prepared	NULL
from	NULL
this	NULL
plasmid	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
59	NULL
)	NULL
.	NULL

Quantification	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
Expression	NULL
in	NULL
Transfected	NULL
Cells	NULL
.	NULL

TNF-	NULL
Â«	NULL
mRNA	NULL
expression	NULL
was	NULL
quantified	NULL
by	NULL
using	NULL
an	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

Transformed	NULL
THP	NULL
-1	NULL
cells	NULL
(	NULL
2	NULL
%	NULL
10Â°	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
200	NULL
nM	NULL
of	NULL
PMA	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
20	NULL
hr	NULL
to	NULL
induce	NULL
differentiation	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
100	NULL
ng/ml	NULL
of	NULL
P.	NULL
gingivalis	NULL
LPS	NULL
(	NULL
54	NULL
)	NULL
for	NULL
2	NULL
hr	NULL
.	NULL

mRNA	NULL
was	NULL
recovered	NULL
from	NULL
the	NULL
cells	NULL
as	NULL
described	NULL
previously	NULL
.	NULL

Successful	NULL
recovery	NULL
of	NULL
mRNA	NULL
from	NULL
each	NULL
sample	NULL
was	NULL
monitored	NULL
by	NULL
Northern	NULL
blot	NULL
hybridization	NULL
with	NULL
a	NULL
B-actin	NULL
probe	NULL
.	NULL

The	NULL
355-bp	NULL
TNF-	NULL
Â«	NULL
cDNA	NULL
was	NULL
obtained	NULL
from	NULL
a	NULL
PMA-induced	NULL
human	NULL
THP-1	NULL
Uni-ZAP	NULL
XR	NULL
cDNA	NULL
library	NULL
(	NULL
Stratagene	NULL
)	NULL
by	NULL
PCR	NULL
with	NULL
specific	NULL
primers	NULL
for	NULL
TNF-a	NULL
mRNA	NULL
(	NULL
Strat-agene	NULL
)	NULL
.	NULL

After	NULL
the	NULL
cDNA	NULL
was	NULL
subcloned	NULL
to	NULL
a	NULL
Smal	NULL
site	NULL
of	NULL
pGEMT7Zf	NULL
(	NULL
+	NULL
)	NULL
,	NULL
the	NULL
TNF-a	NULL
cDNA	NULL
was	NULL
identified	NULL
by	NULL
sequencing	NULL
.	NULL

After	NULL
the	NULL
plasmid	NULL
was	NULL
linearized	NULL
with	NULL
XbaI	NULL
and	NULL
transcribed	NULL
with	NULL
SP6	NULL
polymerase	NULL
,	NULL
a	NULL
446-bp	NULL
*S-labeled	NULL
antisense	NULL
probe	NULL
was	NULL
con-structed	NULL
.	NULL

The	NULL
RNase	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
59	NULL
)	NULL
.	NULL

FISH	NULL
.	NULL

The	NULL
LIT	NULL
AF	NULL
full-length	NULL
cDNA	NULL
probe	NULL
was	NULL
nick-translated	NULL
with	NULL
biotin	NULL
by	NULL
using	NULL
kit	NULL
no	NULL
.	NULL

$	NULL
4099	NULL
(	NULL
Oncor	NULL
)	NULL
according	NULL
to	NULL
the	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

One-half	NULL
microgram	NULL
of	NULL
human	NULL
Cot-1	NULL
DNA	NULL
and	NULL
75	NULL
ug	NULL
of	NULL
salmon	NULL
sperm	NULL
DNA	NULL
were	NULL
resuspended	NULL
in	NULL
50	NULL
pul	NULL
of	NULL
hybrisol	NULL
VII	NULL
(	NULL
catalog	NULL
no	NULL
.	NULL

$	NULL
1390-10	NULL
;	NULL
Oncor	NULL
)	NULL
by	NULL
sonication	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
denatured	NULL
at	NULL
70Â°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
incubated	NULL
at	NULL
37Â°C	NULL
for	NULL
30	NULL
min	NULL
for	NULL
biotin	NULL
labeling	NULL
before	NULL
mixing	NULL
with	NULL
the	NULL
D16Z1	NULL
probe	NULL
.	NULL

A	NULL
digoxygenin-labeled	NULL
D16Z1	NULL
Chromosome	NULL
16	NULL
a-satellite	NULL
Probe	NULL
(	NULL
catalog	NULL
no	NULL
.	NULL

P5035-DG-5	NULL
;	NULL
Oncor	NULL
)	NULL
was	NULL
denatured	NULL
at	NULL
70Â°C	NULL
for	NULL
5	NULL
min	NULL
and	NULL
used	NULL
to	NULL
confirm	NULL
the	NULL
location	NULL
of	NULL
the	NULL
LITAF	NULL
gene	NULL
on	NULL
chromosome	NULL
16	NULL
.	NULL

Normal	NULL
lymphocytes	NULL
were	NULL
treated	NULL
with	NULL
colce-mid	NULL
to	NULL
arrest	NULL
cell	NULL
division	NULL
,	NULL
harvested	NULL
,	NULL
fixed	NULL
,	NULL
and	NULL
placed	NULL
onto	NULL
slides	NULL
according	NULL
to	NULL
standard	NULL
cytogenetic	NULL
protocols	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
denatured	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
plus	NULL
70	NULL
%	NULL
formamide	NULL
at	NULL
72Â°C	NULL
for	NULL
2	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
dehydration	NULL
in	NULL
a	NULL
series	NULL
of	NULL
ethanol	NULL
rinses	NULL
.	NULL

Equal	NULL
volumes	NULL
of	NULL
labeled	NULL
,	NULL
denatured	NULL
probes	NULL
were	NULL
mixed	NULL
,	NULL
and	NULL
20	NULL
ul	NULL
was	NULL
added	NULL
to	NULL
each	NULL
dehydrated	NULL
slide	NULL
.	NULL

Hybridization	NULL
proceeded	NULL
for	NULL
15-17	NULL
hr	NULL
at	NULL
37Â°C	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
washed	NULL
for	NULL
15	NULL
min	NULL
at	NULL
43Â°C	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
plus	NULL
65	NULL
%	NULL
formamide	NULL
and	NULL
then	NULL
at	NULL
37Â°C	NULL
for	NULL
8	NULL
min	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
.	NULL

The	NULL
biotin-labeled	NULL
probe	NULL
was	NULL
detected	NULL
by	NULL
binding	NULL
to	NULL
avidin-Texas	NULL
red	NULL
,	NULL
washed	NULL
,	NULL
amplified	NULL
with	NULL
antiavidin	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
amplified	NULL
with	NULL
avidin-Texas	NULL
red	NULL
by	NULL
using	NULL
the	NULL
Biotin-Texas	NULL
Red	NULL
Detection	NULL
Kit	NULL
(	NULL
catalog	NULL
no	NULL
.	NULL

$	NULL
1334-BTR	NULL
;	NULL
Oncor	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
digoxygenin-labeled	NULL
hybridized	NULL
probe	NULL
was	NULL
detected	NULL
with	NULL
FITC-labeled	NULL
antidigoxygenin	NULL
antibody	NULL
,	NULL
washed	NULL
,	NULL
amplified	NULL
with	NULL
rabbit-anti-sheep	NULL
antibody	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
amplified	NULL
with	NULL
FITC-anti-rabbit	NULL
antibody	NULL
(	NULL
Digoxygenin-FITC	NULL
Detection	NULL
Kit	NULL
,	NULL
Cat	NULL
.	NULL

No	NULL
.	NULL

Â§1331-DF	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
counterstained	NULL
with	NULL
4',6-diamidino-2-phenylindole	NULL
and	NULL
photographed	NULL
by	NULL
using	NULL
triple-excitation	NULL
/emission	NULL
bandpass	NULL
filters	NULL
(	NULL
Cat	NULL
.	NULL

No	NULL
61002X	NULL
%	NULL
X	NULL
;	NULL
Olympus	NULL
,	NULL
New	NULL
Hyde	NULL
Park	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

RESULTS	NULL
Screening	NULL
,	NULL
Sequencing	NULL
,	NULL
and	NULL
Structural	NULL
Analysis	NULL
of	NULL
LITAF	NULL
cDNA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
the	NULL
cDNA	NULL
consists	NULL
of	NULL
a	NULL
234-nt	NULL
5	NULL
'	NULL
noncoding	NULL
region	NULL
,	NULL
a	NULL
687-nt	NULL
ORF	NULL
,	NULL
and	NULL
an	NULL
852-nt	NULL
3	NULL
'	NULL
noncoding	NULL
region	NULL
that	NULL
includes	NULL
a	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
signal	NULL
.	NULL

The	NULL
ORF	NULL
encodes	NULL
a	NULL
228-aa	NULL
,	NULL
23.9-kDa	NULL
protein	NULL
(	NULL
GenBank	NULL
accession	NULL
no	NULL
.	NULL

U77396	NULL
)	NULL
.	NULL

At	NULL
the	NULL
time	NULL
that	NULL
the	NULL
DNA	NULL
sequencing	NULL
was	NULL
almost	NULL
completed	NULL
,	NULL
the	NULL
clone	NULL
was	NULL
entered	NULL
in	NULL
GenBank	NULL
as	NULL
TNF-	NULL
Â«	NULL
-induced	NULL
mRNA	NULL
and	NULL
did	NULL
not	NULL
have	NULL
any	NULL
homology	NULL
with	NULL
nucleotide	NULL
and	NULL
protein	NULL
sequences	NULL
available	NULL
in	NULL
all	NULL
public	NULL
databases	NULL
.	NULL

Polyak	NULL
et	NULL
al	NULL
.	NULL

(	NULL
62	NULL
)	NULL
then	NULL
examined	NULL
transcripts	NULL
markedly	NULL
induced	NULL
by	NULL
the	NULL
p53	NULL
gene	NULL
.	NULL

Among	NULL
them	NULL
,	NULL
an	NULL
expressed	NULL
sequence	NULL
tag	NULL
named	NULL
PIG7	NULL
was	NULL
found	NULL
to	NULL
harbor	NULL
98	NULL
%	NULL
homology	NULL
with	NULL
TNF-	NULL
Â«	NULL
-induced	NULL
mRNA	NULL
(	NULL
62	NULL
)	NULL
.	NULL

We	NULL
have	NULL
,	NULL
in	NULL
the	NULL
present	NULL
report	NULL
,	NULL
renamed	NULL
this	NULL
cDNA	NULL
LITAF	NULL
because	NULL
it	NULL
is	NULL
induced	NULL
by	NULL
LPS	NULL
and	NULL
affects	NULL
TNF-a	NULL
gene	NULL
expression	NULL
.	NULL

Induction	NULL
of	NULL
LITAF	NULL
Gene	NULL
mRNA	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
clearly	NULL
indicated	NULL
that	NULL
a	NULL
single	NULL
1.8-kb	NULL
mRNA	NULL
encoding	NULL
the	NULL
LITAF	NULL
gene	NULL
was	NULL
present	NULL
in	NULL
LPS-induced	NULL
PMA-differentiated	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
transcript	NULL
was	NULL
consistent	NULL
with	NULL
the	NULL
sequence	NULL
data	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
LITAF	NULL
gene	NULL
occurred	NULL
only	NULL
in	NULL
LPS-induced	NULL
,	NULL
PMA-differentiated	NULL
THP	NULL
-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

No	NULL
signal	NULL
was	NULL
found	NULL
in	NULL
PMA-differentiated	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
LPS	NULL
stimulation	NULL
,	NULL
in	NULL
LPS-stimulated	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
PMA	NULL
differentiation	NULL
,	NULL
or	NULL
in	NULL
unstimulated	NULL
THP-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Expression	NULL
Patterns	NULL
of	NULL
the	NULL
Novel	NULL
Gene	NULL
in	NULL
Human	NULL
Tissues	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
a	NULL
1.8-kb	NULL
transcript	NULL
was	NULL
significantly	NULL
expressed	NULL
in	NULL
spleen	NULL
,	NULL
lymph	NULL
node	NULL
,	NULL
and	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
.	NULL

Moderate	NULL
expression	NULL
was	NULL
observed	NULL
in	NULL
thymus	NULL
,	NULL
appendix	NULL
,	NULL
bone	NULL
marrow	NULL
,	NULL
kidney	NULL
,	NULL
and	NULL
placenta	NULL
.	NULL

Little	NULL
expression	NULL
was	NULL
found	NULL
in	NULL
pancreas	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
liver	NULL
,	NULL
and	NULL
lung	NULL
whereas	NULL
a	NULL
very	NULL
minor	NULL
expression	NULL
was	NULL
observed	NULL
in	NULL
heart	NULL
,	NULL
brain	NULL
,	NULL
and	NULL
fetal	NULL
liver	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
transcripts	NULL
again	NULL
was	NULL
consistent	NULL
with	NULL
the	NULL
sequence	NULL
results	NULL
and	NULL
confirms	NULL
that	NULL
the	NULL
cDNA	NULL
isolated	NULL
was	NULL
the	NULL
full-length	NULL
clone	NULL
.	NULL

Antisense	NULL
and	NULL
Sense	NULL
LITAF	NULL
mRNA	NULL
Constructs	NULL
and	NULL
Expression	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
biological	NULL
activity	NULL
of	NULL
the	NULL
isolated	NULL
LITAF	NULL
gene	NULL
,	NULL
THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
following	NULL
constructs	NULL
:	NULL
LITAF	NULL
antisense	NULL
RNA	NULL
(	NULL
AS5	NULL
'	NULL
)	NULL
,	NULL
LITAF	NULL
sense	NULL
RNA	NULL
construct	NULL
(	NULL
s	NULL
)	NULL
,	NULL
or	NULL
vector	NULL
alone	NULL
.	NULL

Using	NULL
LITAF	NULL
antisense	NULL
RNA	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
a	NULL
1.8-kb	NULL
transcript	NULL
was	NULL
detected	NULL
in	NULL
sense-transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
,	NULL
and	NULL
Immunology	NULL
:	NULL
Myokai	NULL
et	NULL
al	NULL
.	NULL

or	NULL
a	NULL
acccen	NULL
Bd	NULL
acron	NULL
nereaccenasceasce	NULL
c	NULL
azo	NULL
r	NULL
cscaccecsee	NULL
180	NULL
rccea	NULL
ccercercesc	NULL
a	NULL
240	NULL
wos	NULL
v	NULL
3	NULL
c	NULL
3	NULL
POG	NULL
Bo	NULL
g	NULL
A	NULL
A	NULL
T	NULL
a	NULL
Pos	NULL
s	NULL
A	NULL
pos	NULL
A	NULL
BoP	NULL
s	NULL
t	NULL
23	NULL
a	NULL
a	NULL
coreacetcerserces	NULL
360	NULL
som	NULL
m	NULL
v	NULL
A	NULL
v	NULL
wos	NULL
voy	NULL
rot	NULL
ror	NULL
a	NULL
row	NULL
Â»	NULL
Goro	NULL
4s	NULL
rc	NULL
mom	NULL
e	NULL
L	NULL
v	NULL
m	NULL
s	NULL
r	NULL
b	NULL
6	NULL
R	NULL
c	NULL
Mow	NULL
Poros	NULL
x	NULL
x	NULL
r	NULL
ced	NULL
ammacramtccnamemn	NULL
coremcoreca	NULL
aso	NULL
g	NULL
Boa	NULL
Bor	NULL
bow	NULL
wow	NULL
r	NULL
of	NULL
mov	NULL
g	NULL
mov	NULL
x	NULL
v	NULL
g	NULL
om	NULL
as	NULL
a	NULL
K	NULL
acaaonten	NULL
.	NULL

s40	NULL
por	NULL
mor	NULL
L	NULL
b	NULL
Â®	NULL
ror	NULL
g	NULL
m	NULL
c	NULL
cor	NULL
s	NULL
co	NULL
K	NULL
oI	NULL
103	NULL
rcoreaorca	NULL
aceee	NULL
soo	NULL
vos	NULL
o	NULL
Los	NULL
v	NULL
w	NULL
a	NULL
e	NULL
a	NULL
now	NULL
w	NULL
n	NULL
s	NULL
coe	NULL
s	NULL
L	NULL
c	NULL
iss	NULL
rom	NULL
s	NULL
vow	NULL
s	NULL
e	NULL
b	NULL
t	NULL
t	NULL
k	NULL
rob	NULL
Lor	NULL
s	NULL
cor	NULL
A	NULL
c	NULL
ids	NULL
acomeenceamractercccan	NULL
cracan	NULL
terms	NULL
720	NULL
Â®	NULL
e	NULL
rob	NULL
nos	NULL
q	NULL
b	NULL
g	NULL
s	NULL
s	NULL
ros	NULL
a	NULL
L	NULL
o	NULL
A	NULL
Pov	NULL
c	NULL
163	NULL
erctcaaccaac	NULL
c	NULL
so	NULL
g	NULL
mow	NULL
ros	NULL
rog	NULL
a	NULL
A	NULL
G	NULL
s	NULL
Por	NULL
#	NULL
n	NULL
s	NULL
s	NULL
s	NULL
is	NULL
corerces	NULL
emc	NULL
sao	NULL
Â®	NULL
w	NULL
ros	NULL
s	NULL
e	NULL
s	NULL
a	NULL
mov	NULL
vos	NULL
Poh	NULL
g	NULL
c	NULL
A	NULL
Â®	NULL
p	NULL
m	NULL
203	NULL
anevern	NULL
Â»	NULL
macercocaraacra	NULL
a	NULL
vor	NULL
Â®	NULL
wos	NULL
s	NULL
v	NULL
v	NULL
A	NULL
k	NULL
b	NULL
mow	NULL
D	NULL
q	NULL
t	NULL
ror	NULL
1	NULL
a	NULL
223	NULL
rs	NULL
mrecamaerch	NULL
aercenceor	NULL
|	NULL
950	NULL
A	NULL
wos	NULL
Roa	NULL
+	NULL
228	NULL
rrcoreccreccrenca	NULL
a	NULL
rreccorntecora	NULL
|	NULL
1020	NULL
maror	NULL
Te	NULL
1080	NULL
eccasteremmac	NULL
arcor	NULL
1140	NULL
ceccrena	NULL
cammatcrmnce	NULL
1200	NULL
canmeatorece	NULL
actecaenert	NULL
|	NULL
1260	NULL
c	NULL
weter	NULL
1320	NULL
anmmaccconeracacnonmntccachacercoranatecntectacaaaRMTRGeccr	NULL
|	NULL
1380	NULL
ceaterar	NULL
1440	NULL
ccama	NULL
rermere	NULL
roreomeny	NULL
1500	NULL
m	NULL
rrromci	NULL
az	NULL
isso	NULL
a	NULL
a	NULL
a	NULL
1620	NULL
coona	NULL
ma	NULL
a	NULL
maga	NULL
1680	NULL
cencen	NULL
e	NULL
are	NULL
mecca	NULL
1740	NULL
amematerencen	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
LITAF	NULL
and	NULL
its	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
.	NULL

The	NULL
full-length	NULL
LITAF	NULL
cDNA	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
cDNA	NULL
library	NULL
of	NULL
PMA-differentiated	NULL
THP-1	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
.	NULL

This	NULL
sequence	NULL
has	NULL
been	NULL
submitted	NULL
to	NULL
GenBank	NULL
and	NULL
has	NULL
been	NULL
assigned	NULL
accession	NULL
no	NULL
.	NULL

U77396	NULL
.	NULL

The	NULL
ORF	NULL
encodes	NULL
228	NULL
aa	NULL
with	NULL
a	NULL
predicted	NULL
molecular	NULL
mass	NULL
of	NULL
23.9	NULL
kDa	NULL
.	NULL

The	NULL
Alu	NULL
sequence	NULL
is	NULL
underlined	NULL
.	NULL

using	NULL
LITAF	NULL
sense	NULL
RNA	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
we	NULL
detected	NULL
a	NULL
band	NULL
of	NULL
approximately	NULL
400	NULL
bp	NULL
in	NULL
antisense-transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

No	NULL
signal	NULL
was	NULL
detected	NULL
in	NULL
mock-transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
antisense	NULL
construction	NULL
design	NULL
.	NULL

Subsequent	NULL
examination	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
inhibiting	NULL
LITAF	NULL
RNA	NULL
using	NULL
LITAF	NULL
antisense	NULL
constructs	NULL
on	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
TNF-	NULL
Â«	NULL
gene	NULL
revealed	NULL
that	NULL
TNF-	NULL
Â«	NULL
mRNA	NULL
signals	NULL
were	NULL
reduced	NULL
more	NULL
strongly	NULL
in	NULL
LITAF	NULL
antisense-expressing	NULL
cells	NULL
than	NULL
in	NULL
mock-transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

No	NULL
changes	NULL
in	NULL
TNF-	NULL
Â«	NULL
mRNA	NULL
signals	NULL
were	NULL
observed	NULL
with	NULL
LITAF	NULL
sense-expressing	NULL
cells	NULL
compared	NULL
with	NULL
mock-transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Similar	NULL
amounts	NULL
of	NULL
B-actin	NULL
mRNA	NULL
were	NULL
found	NULL
in	NULL
LITAF	NULL
antisense-expressing	NULL
cells	NULL
,	NULL
LITAF	NULL
sense-expressing	NULL
cells	NULL
,	NULL
and	NULL
mock-transfected	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Chromosome	NULL
Localization	NULL
.	NULL

FISH	NULL
of	NULL
the	NULL
LITAF	NULL
cDNA	NULL
probe	NULL
to	NULL
human	NULL
metaphase	NULL
spreads	NULL
resulted	NULL
in	NULL
specific	NULL
labeling	NULL
on	NULL
chromosome	NULL
16	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
location	NULL
on	NULL
chromosome	NULL
16	NULL
a	NULL
Â«	NULL
-sat-	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Northern	NULL
blot	NULL
hybridization	NULL
of	NULL
mRNA	NULL
from	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
107	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
various	NULL
conditions	NULL
:	NULL
stimulation	NULL
with	NULL
P.	NULL
gingivalis	NULL
LPS	NULL
(	NULL
LPS	NULL
)	NULL
;	NULL
differentiation	NULL
with	NULL
PMA	NULL
(	NULL
PMA	NULL
)	NULL
;	NULL
differentiation	NULL
with	NULL
PMA	NULL
followed	NULL
by	NULL
stimulation	NULL
with	NULL
LPS	NULL
(	NULL
PMA+LPS	NULL
)	NULL
;	NULL
and	NULL
no	NULL
stimulation	NULL
(	NULL
plain	NULL
)	NULL
.	NULL

The	NULL
mRNA	NULL
was	NULL
recovered	NULL
from	NULL
cells	NULL
,	NULL
run	NULL
on	NULL
denaturing	NULL
formaldehyde/1.2	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
Hybond-N*	NULL
filter	NULL
.	NULL

The	NULL
filter	NULL
was	NULL
hybridized	NULL
with	NULL
the	NULL
antisense	NULL
RNA	NULL
probe	NULL
that	NULL
corresponded	NULL
to	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
LITAF	NULL
gene	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
hybridized	NULL
filter	NULL
was	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
for	NULL
24	NULL
hr	NULL
.	NULL

A	NULL
1.8-kb	NULL
transcript	NULL
was	NULL
observed	NULL
only	NULL
in	NULL
PMA+LPS-stimulated	NULL
THP-1	NULL
cells	NULL
.	NULL

Similar	NULL
amounts	NULL
of	NULL
B-actin	NULL
mRNA	NULL
were	NULL
found	NULL
in	NULL
all	NULL
mRNA	NULL
tested	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

PMA+LPS	NULL
plain	NULL
Â£3	NULL
-a-	NULL
1.8	NULL
kb	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
4521	NULL
Â©	NULL
A	NULL
B	NULL
Â§	NULL
8	NULL
ax	NULL
E	NULL
@	NULL
Â§	NULL
:	NULL
Â£	NULL
-Â§	NULL
~	NULL
t	NULL
5	NULL
Â£	NULL
=	NULL
.	NULL

8	NULL
â¬	NULL
ug	NULL
6	NULL
P	NULL
2	NULL
kc	NULL
c	NULL
ob	NULL
G	NULL
*	NULL
86g	NULL
?	NULL

rs	NULL
ngS	NULL
>	NULL
EEE	NULL
EE	NULL
;	NULL
Â§	NULL
â	NULL
E=	NULL
k	NULL
a2s	NULL
%	NULL
s	NULL
&	NULL
a	NULL
>	NULL
t	NULL
s	NULL
Aks	NULL
-a-	NULL
9.5	NULL
kb	NULL
me	NULL
Sake	NULL
-a-	NULL
7.5	NULL
kb	NULL
Â«	NULL
a-	NULL
7.5	NULL
kb	NULL
~*~	NULL
4.4	NULL
kb	NULL
-t	NULL
4.4kb	NULL
a	NULL
<	NULL
Al	NULL
a	NULL
wae	NULL
at	NULL
dip	NULL
at	NULL
|	NULL
4	NULL
2.4	NULL
kb	NULL
(	NULL
i	NULL
tite	NULL
wn	NULL
aat	NULL
OB	NULL
an	NULL
.	NULL

~~	NULL
2.4	NULL
kb	NULL
=C	NULL
1.35	NULL
kb	NULL
-t	NULL
1.35kb	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Northern	NULL
blot	NULL
hybridization	NULL
of	NULL
mRNA	NULL
(	NULL
2	NULL
ug	NULL
)	NULL
from	NULL
different	NULL
adult	NULL
tissues	NULL
.	NULL

(	NULL
4	NULL
and	NULL
B	NULL
)	NULL
Expression	NULL
of	NULL
the	NULL
LITAF	NULL
gene	NULL
.	NULL

The	NULL
preblotted	NULL
filters	NULL
(	NULL
CLONTECH	NULL
]	NULL
)	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
antisense	NULL
RNA	NULL
probe	NULL
that	NULL
corresponded	NULL
to	NULL
the	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
LITAF	NULL
gene	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

ellite	NULL
was	NULL
confirmed	NULL
by	NULL
double-labeling	NULL
with	NULL
a	NULL
commercial	NULL
probe	NULL
,	NULL
D16Z2	NULL
(	NULL
Oncor	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
had	NULL
specificity	NULL
for	NULL
this	NULL
site	NULL
,	NULL
because	NULL
symmetrical	NULL
signals	NULL
were	NULL
not	NULL
observed	NULL
on	NULL
other	NULL
chromosomes	NULL
.	NULL

The	NULL
FISH	NULL
signals	NULL
were	NULL
localized	NULL
relative	NULL
to	NULL
the	NULL
chromosome	NULL
bands	NULL
and	NULL
the	NULL
LITAF	NULL
gene	NULL
locus	NULL
assigned	NULL
to	NULL
chromosome	NULL
16	NULL
pl2-16p13.3	NULL
.	NULL

DISCUSSION	NULL
The	NULL
present	NULL
paper	NULL
reports	NULL
the	NULL
cloning	NULL
,	NULL
characterization	NULL
,	NULL
and	NULL
chromosomal	NULL
assignment	NULL
of	NULL
an	NULL
LPS-induced	NULL
gene	NULL
named	NULL
LIT	NULL
AF	NULL
that	NULL
affects	NULL
TNF-a	NULL
gene	NULL
expression	NULL
in	NULL
cells	NULL
of	NULL
monocytic	NULL
lineage	NULL
.	NULL

The	NULL
cDNA	NULL
encoding	NULL
LITAF	NULL
was	NULL
isolated	NULL
by	NULL
screening	NULL
an	NULL
LPS-induced	NULL
THP-1	NULL
expression	NULL
library	NULL
with	NULL
degenerate	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
native	NULL
nuclear	NULL
protein	NULL
isolated	NULL
.	NULL

Functional	NULL
studies	NULL
aimed	NULL
at	NULL
interfering	NULL
with	NULL
LITAF	NULL
mRNA	NULL
expression	NULL
by	NULL
using	NULL
antisense	NULL
RNA	NULL
in	NULL
PMA-differentiated	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
LPS	NULL
resulted	NULL
in	NULL
a	NULL
reduction	NULL
of	NULL
TNF-a	NULL
transcripts	NULL
.	NULL

In	NULL
humans	NULL
this	NULL
gene	NULL
has	NULL
been	NULL
localized	NULL
to	NULL
chromosome	NULL
16p12-16p13.3	NULL
.	NULL

All	NULL
the	NULL
public	NULL
nucleotide	NULL
and	NULL
protein	NULL
sequence	NULL
databases	NULL
were	NULL
searched	NULL
.	NULL

None	NULL
of	NULL
the	NULL
sequences	NULL
in	NULL
the	NULL
coding	NULL
region	NULL
were	NULL
found	NULL
to	NULL
be	NULL
similar	NULL
to	NULL
typical	NULL
DNA-binding	NULL
motifs	NULL
.	NULL

We	NULL
did	NULL
find	NULL
se	NULL
A	NULL
_	NULL
%	NULL
B	NULL
y	NULL
1	NULL
}	NULL
O	NULL
4	NULL
%	NULL
Pr	NULL
$	NULL
2	NULL
2	NULL
2	NULL
8	NULL
o	NULL
Â§	NULL
~	NULL
x	NULL
Â£	NULL
a	NULL
&	NULL
8	NULL
3	NULL
A	NULL
<	NULL
-	NULL
3	NULL
<	NULL
-t-	NULL
1.8	NULL
kb	NULL
-a-	NULL
0.4	NULL
kb	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Northern	NULL
blot	NULL
hybridization	NULL
of	NULL
RNA	NULL
from	NULL
THP-1	NULL
cells	NULL
transfected	NULL
with	NULL
ASS5	NULL
'	NULL
,	NULL
SE	NULL
,	NULL
or	NULL
control	NULL
vector	NULL
(	NULL
MOCK	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
recovered	NULL
from	NULL
2	NULL
X	NULL
10Â°	NULL
cells	NULL
after	NULL
differentiation	NULL
with	NULL
PMA	NULL
and	NULL
stimulation	NULL
with	NULL
P.	NULL
gingivalis	NULL
LPS	NULL
.	NULL

(	NULL
4	NULL
)	NULL
RNAs	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
LITAF	NULL
sense	NULL
RNA	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RNAs	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
LITAF	NULL
antisense	NULL
RNA	NULL
probe	NULL
.	NULL

Similar	NULL
amounts	NULL
of	NULL
B-actin	NULL
mRNA	NULL
were	NULL
found	NULL
in	NULL
LITAF	NULL
antisense-expressing	NULL
cells	NULL
,	NULL
LITAF	NULL
sense-expressing	NULL
cells	NULL
,	NULL
and	NULL
mock-transfected	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

4522	NULL
Immunology	NULL
:	NULL
Myokai	NULL
et	NULL
al	NULL
.	NULL

Loe	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

RNase	NULL
protection	NULL
assay	NULL
of	NULL
$	NULL
5	NULL
g	NULL
RNA	NULL
from	NULL
THP-1	NULL
cells	NULL
transfected	NULL
with	NULL
28	NULL
Â©	NULL
AS5	NULL
'	NULL
,	NULL
SE	NULL
,	NULL
or	NULL
control	NULL
vector	NULL
(	NULL
MOCK	NULL
)	NULL
.	NULL

<	NULL
2	NULL
w	NULL
E	NULL
Total	NULL
RNA	NULL
was	NULL
recovered	NULL
from	NULL
2	NULL
x	NULL
10Â°	NULL
C	NULL
Â£8	NULL
[	NULL
2	NULL
]	NULL
cells	NULL
after	NULL
differentiation	NULL
with	NULL
PMA	NULL
and	NULL
eas4	NULL
<	NULL
stimulation	NULL
with	NULL
P.	NULL
gingivalis	NULL
LPS	NULL
.	NULL

The	NULL
RNAs	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
TNF-a	NULL
@	NULL
antisense	NULL
RNA	NULL
probe	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
RNase	NULL
A	NULL
and	NULL
T1	NULL
,	NULL
protected	NULL
bands	NULL
were	NULL
electrophoresed	NULL
through	NULL
an	NULL
8	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
and	NULL
the	NULL
dried	NULL
gel	NULL
was	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
.	NULL

No	NULL
protected	NULL
band	NULL
is	NULL
observed	NULL
in	NULL
AS5'-transfected	NULL
cells	NULL
.	NULL

The	NULL
band	NULL
density	NULL
observed	NULL
in	NULL
SE-transfected	NULL
cells	NULL
was	NULL
found	NULL
to	NULL
be	NULL
similar	NULL
to	NULL
the	NULL
band	NULL
in	NULL
MOCK	NULL
cells	NULL
.	NULL

Left	NULL
lane	NULL
,	NULL
native	NULL
TNF-a	NULL
antisense	NULL
probe	NULL
.	NULL

--	NULL
446	NULL
base	NULL
-a-	NULL
335	NULL
base	NULL
quences	NULL
in	NULL
two	NULL
other	NULL
regions	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
UTRs	NULL
)	NULL
that	NULL
displayed	NULL
some	NULL
homology	NULL
with	NULL
sequences	NULL
reported	NULL
in	NULL
the	NULL
data-bases	NULL
:	NULL
several	NULL
amino	NULL
acid	NULL
sequences	NULL
were	NULL
found	NULL
to	NULL
be	NULL
similar	NULL
to	NULL
the	NULL
Bicaudal-C	NULL
gene	NULL
of	NULL
Drosophila	NULL
melanogaster	NULL
.	NULL

Although	NULL
the	NULL
Bicaudal-C	NULL
gene	NULL
product	NULL
contains	NULL
a	NULL
motif	NULL
called	NULL
the	NULL
KH	NULL
domain	NULL
,	NULL
which	NULL
is	NULL
found	NULL
in	NULL
many	NULL
RNA	NULL
and	NULL
single-stranded	NULL
DNA-binding	NULL
proteins	NULL
(	NULL
63	NULL
)	NULL
,	NULL
we	NULL
did	NULL
not	NULL
find	NULL
a	NULL
typical	NULL
KH	NULL
domain	NULL
in	NULL
the	NULL
LITAF	NULL
gene	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
sequencing	NULL
of	NULL
the	NULL
LITAF	NULL
gene	NULL
revealed	NULL
Alu	NULL
elements	NULL
in	NULL
the	NULL
3	NULL
'	NULL
noncoding	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Several	NULL
investigators	NULL
have	NULL
reported	NULL
that	NULL
Alu	NULL
elements	NULL
constitute	NULL
approximately	NULL
5	NULL
%	NULL
of	NULL
the	NULL
human	NULL
genome	NULL
and	NULL
often	NULL
are	NULL
found	NULL
in	NULL
introns	NULL
or	NULL
3	NULL
'	NULL
UTRs	NULL
.	NULL

However	NULL
,	NULL
the	NULL
Alu	NULL
region	NULL
mistakenly	NULL
may	NULL
be	NULL
incorporated	NULL
into	NULL
ORFs	NULL
(	NULL
84	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Alu	NULL
element	NULL
was	NULL
a	NULL
result	NULL
of	NULL
alternative	NULL
splicing	NULL
from	NULL
an	NULL
adjacent	NULL
intron	NULL
,	NULL
the	NULL
other	NULL
two	NULL
cognate	NULL
clones	NULL
were	NULL
sequenced	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
cognate	NULL
clones	NULL
significantly	NULL
overlapped	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Alu	NULL
region	NULL
in	NULL
the	NULL
cDNA	NULL
probably	NULL
was	NULL
not	NULL
caused	NULL
by	NULL
a	NULL
splicing	NULL
error	NULL
.	NULL

Recently	NULL
,	NULL
Neuenchwander	NULL
et	NULL
al	NULL
.	NULL

(	NULL
64	NULL
)	NULL
reported	NULL
that	NULL
stable	NULL
antisense	NULL
RNA	NULL
expression	NULL
inhibits	NULL
the	NULL
translation	NULL
of	NULL
sense	NULL
RNA	NULL
.	NULL

In	NULL
a	NULL
number	NULL
of	NULL
studies	NULL
(	NULL
65-68	NULL
)	NULL
,	NULL
stable	NULL
antisense	NULL
RNA	NULL
expression	NULL
has	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
endogenous	NULL
mRNA	NULL
levels	NULL
.	NULL

Although	NULL
the	NULL
mechanism	NULL
responsible	NULL
for	NULL
this	NULL
decrease	NULL
remains	NULL
unclear	NULL
,	NULL
it	NULL
may	NULL
be	NULL
related	NULL
to	NULL
the	NULL
inhibition	NULL
of	NULL
RNA	NULL
synthesis	NULL
,	NULL
RNA	NULL
splicing	NULL
,	NULL
mRNA	NULL
export	NULL
,	NULL
binding	NULL
of	NULL
initiation	NULL
factors	NULL
,	NULL
assembly	NULL
of	NULL
ribosome	NULL
subunits	NULL
,	NULL
and	NULL
sliding	NULL
of	NULL
the	NULL
ribosome	NULL
along	NULL
the	NULL
mRNA	NULL
coding	NULL
sequence	NULL
,	NULL
all	NULL
of	NULL
which	NULL
result	NULL
in	NULL
translation	NULL
arrest	NULL
(	NULL
69	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
attempted	NULL
to	NULL
interfere	NULL
with	NULL
LITAF	NULL
gene	NULL
activity	NULL
at	NULL
the	NULL
mRNA	NULL
level	NULL
by	NULL
transfecting	NULL
antisense	NULL
oligonucleotide-producing	NULL
vectors	NULL
into	NULL
THP-1	NULL
cells	NULL
.	NULL

The	NULL
most	NULL
common	NULL
mRNA	NULL
target	NULL
site	NULL
reported	NULL
in	NULL
the	NULL
literature	NULL
is	NULL
the	NULL
AUG	NULL
translation	NULL
initiation	NULL
codon	NULL
(	NULL
70	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
have	NULL
found	NULL
in	NULL
many	NULL
cases	NULL
that	NULL
oligonucleotides	NULL
that	NULL
target	NULL
other	NULL
regions	NULL
in	NULL
the	NULL
mRNA	NULL
,	NULL
such	NULL
as	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
UTRs	NULL
,	NULL
were	NULL
more	NULL
effective	NULL
(	NULL
71-74	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
to	NULL
interfere	NULL
with	NULL
LITAF	NULL
mRNA	NULL
,	NULL
we	NULL
transfected	NULL
vectors	NULL
producing	NULL
antisense	NULL
oligonucleotides	NULL
that	NULL
target	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
LITAF	NULL
mRNA	NULL
,	NULL
and	NULL
,	NULL
for	NULL
the	NULL
overexpression	NULL
of	NULL
the	NULL
LITAF	NULL
mRNA	NULL
,	NULL
a	NULL
vector	NULL
producing	NULL
the	NULL
full-length	NULL
LITAF	NULL
mRNA	NULL
was	NULL
transfected	NULL
.	NULL

Using	NULL
sense	NULL
LITAF	NULL
RNA	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
a	NULL
band	NULL
of	NULL
approximately	NULL
400	NULL
bp	NULL
was	NULL
detected	NULL
in	NULL
ASS	NULL
``	NULL
-transfected	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
design	NULL
of	NULL
the	NULL
antisense	NULL
vector	NULL
.	NULL

No	NULL
significant	NULL
signal	NULL
was	NULL
detected	NULL
in	NULL
mock-transfected	NULL
cells	NULL
.	NULL

When	NULL
the	NULL
full-length	NULL
sense	NULL
LITAF	NULL
mRNA	NULL
was	NULL
transfected	NULL
in	NULL
THP-1	NULL
cells	NULL
,	NULL
an	NULL
intense	NULL
signal	NULL
for	NULL
LITAF	NULL
mRNA	NULL
was	NULL
detected	NULL
at	NULL
1.8	NULL
kb	NULL
by	NULL
using	NULL
an	NULL
antisense	NULL
LITAF	NULL
mRNA	NULL
probe	NULL
,	NULL
reflecting	NULL
the	NULL
overexpression	NULL
of	NULL
LITAF	NULL
mRNA	NULL
,	NULL
which	NULL
confirmed	NULL
the	NULL
stable	NULL
expression	NULL
of	NULL
RNA	NULL
from	NULL
each	NULL
construct	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
same	NULL
probe	NULL
was	NULL
used	NULL
,	NULL
ASS	NULL
``	NULL
-transfected	NULL
cells	NULL
weakly	NULL
expressed	NULL
the	NULL
LITAF	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
interference	NULL
of	NULL
LITAF	NULL
expression	NULL
with	NULL
the	NULL
antisense	NULL
was	NULL
not	NULL
complete	NULL
and	NULL
LITAF	NULL
antisense-transfected	NULL
cells	NULL
continued	NULL
to	NULL
exhibit	NULL
little	NULL
expression	NULL
of	NULL
the	NULL
LITAF	NULL
gene	NULL
partly	NULL
as	NULL
a	NULL
compensatory	NULL
mechanism	NULL
to	NULL
restore	NULL
the	NULL
function	NULL
,	NULL
although	NULL
the	NULL
mechanisms	NULL
involved	NULL
in	NULL
this	NULL
phenomena	NULL
remain	NULL
unknown	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

FISH	NULL
localization	NULL
of	NULL
human	NULL
LITAF	NULL
gene	NULL
.	NULL

Metaphase	NULL
chromosome	NULL
spread	NULL
after	NULL
hybridization	NULL
with	NULL
a	NULL
biotinylated	NULL
LITAF	NULL
probe	NULL
.	NULL

The	NULL
banding	NULL
is	NULL
observed	NULL
on	NULL
chromosome	NULL
16p12-16p13.3	NULL
.	NULL

Using	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
,	NULL
examination	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
antisense	NULL
RNA	NULL
on	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
TNF-a	NULL
gene	NULL
revealed	NULL
that	NULL
the	NULL
signal	NULL
indicating	NULL
the	NULL
TNF-	NULL
Â«	NULL
mRNA	NULL
level	NULL
was	NULL
weaker	NULL
in	NULL
antisense-expressing	NULL
cells	NULL
than	NULL
in	NULL
mock	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
similar	NULL
amounts	NULL
of	NULL
B-actin	NULL
mRNA	NULL
were	NULL
found	NULL
in	NULL
both	NULL
cells	NULL
.	NULL

The	NULL
reduction	NULL
of	NULL
TNF-	NULL
Â«	NULL
mRNA	NULL
that	NULL
occurs	NULL
when	NULL
LITAF	NULL
gene	NULL
mRNA	NULL
activity	NULL
is	NULL
arrested	NULL
strongly	NULL
suggests	NULL
that	NULL
LITAF	NULL
gene	NULL
products	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
human	NULL
TNF-a	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
TNF-	NULL
Â«	NULL
mRNA	NULL
was	NULL
not	NULL
enhanced	NULL
in	NULL
the	NULL
sense-expressing	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
scope	NULL
of	NULL
our	NULL
functional	NULL
study	NULL
is	NULL
not	NULL
broad	NULL
enough	NULL
for	NULL
us	NULL
to	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
exogenous	NULL
LITAF	NULL
gene	NULL
products	NULL
may	NULL
regulate	NULL
TNF-a	NULL
gene	NULL
transcription	NULL
in	NULL
other	NULL
ways	NULL
than	NULL
what	NULL
occurs	NULL
naturally	NULL
.	NULL

We	NULL
posit	NULL
three	NULL
possibilities	NULL
for	NULL
how	NULL
the	NULL
LITAF	NULL
gene	NULL
product	NULL
may	NULL
regulate	NULL
gene	NULL
transcription	NULL
:	NULL
(	NULL
?	NULL
)	NULL

the	NULL
LITAF	NULL
gene	NULL
may	NULL
have	NULL
to	NULL
be	NULL
processed	NULL
as	NULL
a	NULL
protein	NULL
to	NULL
activate	NULL
the	NULL
TNF-a	NULL
gene	NULL
;	NULL
(	NULL
i	NULL
)	NULL
the	NULL
endogenous	NULL
LITAF	NULL
gene	NULL
product	NULL
is	NULL
enough	NULL
to	NULL
activate	NULL
the	NULL
TNF-a	NULL
gene	NULL
;	NULL
and	NULL
(	NULL
#	NULL
?	NULL
)	NULL

the	NULL
exogenous	NULL
LITAF	NULL
gene	NULL
product	NULL
acts	NULL
after	NULL
protein	NULL
processing	NULL
because	NULL
a	NULL
large	NULL
amount	NULL
of	NULL
LITAF	NULL
mRNA	NULL
is	NULL
constitutively	NULL
transcribed	NULL
in	NULL
the	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Nonetheless	NULL
,	NULL
the	NULL
present	NULL
data	NULL
support	NULL
recent	NULL
data	NULL
suggesting	NULL
that	NULL
LPS	NULL
induction	NULL
of	NULL
TNF-a	NULL
promoter	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
concerted	NULL
participation	NULL
of	NULL
at	NULL
least	NULL
two	NULL
separate	NULL
,	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
(	NULL
75	NULL
)	NULL
.	NULL

Distribution	NULL
of	NULL
LITAF	NULL
mRNA	NULL
on	NULL
various	NULL
tissue	NULL
blots	NULL
revealed	NULL
that	NULL
the	NULL
LITAF	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
most	NULL
of	NULL
the	NULL
tissues	NULL
tested	NULL
;	NULL
however	NULL
,	NULL
it	NULL
is	NULL
expressed	NULL
more	NULL
predominantly	NULL
in	NULL
hematolympho-poeitic	NULL
tissues	NULL
and	NULL
placenta	NULL
,	NULL
kidney	NULL
,	NULL
and	NULL
pancreas	NULL
.	NULL

This	NULL
distribution	NULL
of	NULL
LITAF	NULL
transcripts	NULL
seems	NULL
to	NULL
parallel	NULL
TNF-a	NULL
tissue	NULL
distribution	NULL
during	NULL
endotoxemia	NULL
(	NULL
76	NULL
,	NULL
77	NULL
)	NULL
.	NULL

The	NULL
potential	NULL
role	NULL
of	NULL
LITAF	NULL
in	NULL
human	NULL
disease	NULL
is	NULL
implicated	NULL
by	NULL
the	NULL
recent	NULL
finding	NULL
that	NULL
p53	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
LITAF	NULL
gene	NULL
(	NULL
62	NULL
)	NULL
and	NULL
by	NULL
its	NULL
chromosomal	NULL
localization	NULL
at	NULL
16p12-16p13.3	NULL
.	NULL

The	NULL
p53	NULL
tumor-suppressor	NULL
protein	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
defense	NULL
of	NULL
the	NULL
cell	NULL
against	NULL
agents	NULL
that	NULL
damage	NULL
DNA	NULL
(	NULL
78	NULL
,	NULL
79	NULL
)	NULL
.	NULL

Loss	NULL
of	NULL
function	NULL
of	NULL
the	NULL
p53	NULL
tumor-suppressor	NULL
gene	NULL
is	NULL
a	NULL
frequent	NULL
and	NULL
important	NULL
event	NULL
in	NULL
the	NULL
genesis	NULL
or	NULL
progression	NULL
of	NULL
many	NULL
human	NULL
malignancies	NULL
.	NULL

Loss	NULL
of	NULL
p53-dependent	NULL
apoptosis	NULL
is	NULL
believed	NULL
to	NULL
be	NULL
critical	NULL
to	NULL
carcinogenesis	NULL
in	NULL
many	NULL
of	NULL
these	NULL
cases	NULL
,	NULL
suggesting	NULL
the	NULL
possibility	NULL
to	NULL
therapeutically	NULL
restore	NULL
this	NULL
pathway	NULL
and	NULL
directly	NULL
eliminate	NULL
malignant	NULL
cells	NULL
or	NULL
increase	NULL
or	NULL
restore	NULL
their	NULL
sensitivity	NULL
to	NULL
chemotherapeutic	NULL
agents	NULL
(	NULL
78	NULL
,	NULL
79	NULL
)	NULL
.	NULL

The	NULL
regulation	NULL
of	NULL
p53-dependent	NULL
responses	NULL
is	NULL
complex	NULL
and	NULL
variable	NULL
between	NULL
cell	NULL
types	NULL
,	NULL
and	NULL
whether	NULL
a	NULL
cell	NULL
undergoes	NULL
apoptosis	NULL
after	NULL
activation	NULL
of	NULL
p53	NULL
is	NULL
highly	NULL
sensitive	NULL
to	NULL
signal	NULL
context	NULL
,	NULL
including	NULL
environmental	NULL
and	NULL
cell-intrinsic	NULL
influences	NULL
.	NULL

Further	NULL
insight	NULL
has	NULL
been	NULL
provided	NULL
into	NULL
the	NULL
activation	NULL
of	NULL
latent	NULL
p53	NULL
,	NULL
the	NULL
biochemical	NULL
mechanisms	NULL
involved	NULL
in	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
,	NULL
and	NULL
the	NULL
influence	NULL
of	NULL
various	NULL
signals	NULL
on	NULL
these	NULL
cellular	NULL
effects	NULL
.	NULL

Additionally	NULL
,	NULL
roles	NULL
for	NULL
p53	NULL
Immunology	NULL
:	NULL
Myokai	NULL
et	NULL
al	NULL
.	NULL

have	NULL
been	NULL
described	NULL
in	NULL
cell	NULL
senescence	NULL
,	NULL
suppressing	NULL
teratogenesis	NULL
,	NULL
and	NULL
processes	NULL
that	NULL
may	NULL
contribute	NULL
directly	NULL
to	NULL
the	NULL
maintenance	NULL
of	NULL
genomic	NULL
stability	NULL
(	NULL
78	NULL
,	NULL
79	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
various	NULL
monocytic	NULL
cell	NULL
lines	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
respond	NULL
to	NULL
LPS	NULL
and	NULL
interferon	NULL
y	NULL
with	NULL
endogenous	NULL
nitric	NULL
oxide	NULL
(	NULL
NO	NULL
)	NULL
formation	NULL
(	NULL
80	NULL
)	NULL
,	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
activates	NULL
the	NULL
expression	NULL
of	NULL
p53	NULL
,	NULL
leading	NULL
to	NULL
apoptosis	NULL
(	NULL
81	NULL
)	NULL
.	NULL

Fur-thermore	NULL
,	NULL
p53	NULL
has	NULL
been	NULL
shown	NULL
recently	NULL
to	NULL
modulate	NULL
the	NULL
activity	NULL
of	NULL
various	NULL
inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-6	NULL
(	NULL
82	NULL
)	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
IL-4	NULL
(	NULL
83	NULL
)	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
present	NULL
data	NULL
,	NULL
a	NULL
potential	NULL
,	NULL
new	NULL
pS53-dependent	NULL
pathway	NULL
affecting	NULL
TNF-a	NULL
gene	NULL
expression	NULL
can	NULL
be	NULL
proposed	NULL
:	NULL
LPS	NULL
stimulation	NULL
of	NULL
monocyte	NULL
/macrophages	NULL
can	NULL
induce	NULL
NO	NULL
production	NULL
.	NULL

In	NULL
turn	NULL
,	NULL
NO	NULL
can	NULL
up-regulate	NULL
p53	NULL
,	NULL
which	NULL
would	NULL
stimulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
LITAF	NULL
gene	NULL
.	NULL

Ultimately	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
LITAF	NULL
gene	NULL
product	NULL
would	NULL
affect	NULL
TNF-a	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
validity	NULL
of	NULL
this	NULL
pathway	NULL
remains	NULL
to	NULL
be	NULL
substan-tiated	NULL
.	NULL

Altogether	NULL
,	NULL
the	NULL
present	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
novel	NULL
LITAF	NULL
gene	NULL
product	NULL
might	NULL
be	NULL
a	NULL
crucial	NULL
factor	NULL
for	NULL
the	NULL
control	NULL
of	NULL
TNF-a	NULL
gene	NULL
expression	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institute	NULL
of	NULL
Craniofacial	NULL
and	NULL
Dental	NULL
Research	NULL
Grant	NULL
DE10709	NULL
to	NULL
S.A.	NULL
Morrison	NULL
,	NULL
D.	NULL
C.	NULL
&	NULL
Ryan	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Med	NULL
.	NULL

38	NULL
,	NULL
417-432	NULL
.	NULL

Marrack	NULL
,	NULL
P.	NULL
&	NULL
Kappler	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
705-711	NULL
.	NULL

Bazzoni	NULL
,	NULL
F.	NULL
&	NULL
Beutler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Inflamm	NULL
.	NULL

45	NULL
,	NULL
106-114	NULL
.	NULL

Beutler	NULL
,	NULL
B.	NULL
,	NULL
Milsark	NULL
,	NULL
I.	NULL
W.	NULL
&	NULL
Cerami	NULL
,	NULL
A.	NULL
C.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
229	NULL
,	NULL
869-871	NULL
.	NULL

Bone	NULL
,	NULL
R.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Ann	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

115	NULL
,	NULL
457-469	NULL
.	NULL

Cannon	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Tompkins	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
Gelfand	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Michie	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Stanford	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
van	NULL
der	NULL
Meer	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Endres	NULL
,	NULL
S.	NULL
,	NULL
Lonnemann	NULL
,	NULL
G.	NULL
,	NULL
Corsetti	NULL
,	NULL
J.	NULL
,	NULL
Chernow	NULL
,	NULL
B.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

161	NULL
,	NULL
79-84	NULL
.	NULL

7	NULL
.	NULL

Chai	NULL
,	NULL
Z.	NULL
,	NULL
Gatti	NULL
,	NULL
S.	NULL
,	NULL
Toniatti	NULL
,	NULL
C.	NULL
,	NULL
Poli	NULL
,	NULL
V.	NULL
&	NULL
Bartfai	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
,	NULL
311-316	NULL
.	NULL

8	NULL
.	NULL

-	NULL
Dayer	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Beutler	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

162	NULL
,	NULL
2163-2168	NULL
.	NULL

9	NULL
.	NULL

Zheng	NULL
,	NULL
H.	NULL
,	NULL
Fletcher	NULL
,	NULL
D.	NULL
,	NULL
Kozak	NULL
,	NULL
W.	NULL
,	NULL
Jiang	NULL
,	NULL
M.	NULL
,	NULL
Hofmann	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Conn	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Soszynski	NULL
,	NULL
D.	NULL
,	NULL
Grabiec	NULL
,	NULL
C.	NULL
,	NULL
Trumbauer	NULL
,	NULL
M.	NULL
E.	NULL
&	NULL
Shaw	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Immunity	NULL
3	NULL
,	NULL
9-19	NULL
.	NULL

10	NULL
.	NULL

Gordon	NULL
,	NULL
A.	NULL
H.	NULL
&	NULL
Koj	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
in	NULL
The	NULL
Acute-Phase	NULL
Response	NULL
to	NULL
Injury	NULL
and	NULL
Infection	NULL
,	NULL
eds	NULL
.	NULL

Gordon	NULL
,	NULL
A.	NULL
H.	NULL
&	NULL
Koj	NULL
,	NULL
A	NULL
.	NULL

(	NULL
Elsevier	NULL
,	NULL
Amsterdam	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

139-149	NULL
.	NULL

11	NULL
.	NULL

Blatteis	NULL
,	NULL
C.	NULL
M.	NULL
&	NULL
Sehic	NULL
,	NULL
E.	NULL
(	NULL
1998	NULL
)	NULL
Ann	NULL
.	NULL

N.	NULL
Y.	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

840	NULL
,	NULL
608-618	NULL
.	NULL

12	NULL
.	NULL

Tracey	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Beutler	NULL
,	NULL
B.	NULL
,	NULL
Lowry	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Merryweather	NULL
,	NULL
J.	NULL
,	NULL
Wolpe	NULL
,	NULL
S.	NULL
,	NULL
Milsark	NULL
,	NULL
I.	NULL
W.	NULL
,	NULL
Hariri	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Fahey	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Zentella	NULL
,	NULL
A.	NULL
,	NULL
Albert	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Science	NULL
234	NULL
,	NULL
470-474	NULL
.	NULL

13	NULL
.	NULL

Micthke	NULL
,	NULL
T.	NULL
,	NULL
Wahl	NULL
,	NULL
C.	NULL
,	NULL
Heeg	NULL
,	NULL
K.	NULL
,	NULL
Echtenacher	NULL
,	NULL
B.	NULL
,	NULL
Krammer	NULL
,	NULL
P.	NULL
H.	NULL
&	NULL
Wagner	NULL
,	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
,	NULL
91-98	NULL
.	NULL

14	NULL
.	NULL

Beutler	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
320	NULL
,	NULL
584-588	NULL
.	NULL

15	NULL
.	NULL

Beutler	NULL
,	NULL
B.	NULL
,	NULL
Krochin	NULL
,	NULL
N.	NULL
,	NULL
Milsark	NULL
,	NULL
I.	NULL
W.	NULL
,	NULL
Leudke	NULL
,	NULL
C.	NULL
&	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Science	NULL
232	NULL
,	NULL
977-980	NULL
.	NULL

16	NULL
.	NULL

Beutler	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

316	NULL
,	NULL
379-385	NULL
.	NULL

17	NULL
.	NULL

Sugarman	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Aggarwal	NULL
,	NULL
B	NULL
.	NULL

B.	NULL
,	NULL
Hass	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
Figari	NULL
,	NULL
I.	NULL
S.	NULL
,	NULL
Palladino	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Shepard	NULL
,	NULL
H.	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
230	NULL
,	NULL
943-945	NULL
.	NULL

18	NULL
.	NULL

Alexander	NULL
,	NULL
H.	NULL
R.	NULL
,	NULL
Sheppard	NULL
,	NULL
B.	NULL
C.	NULL
,	NULL
Jensen	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Langstein	NULL
,	NULL
H.	NULL
N.	NULL
,	NULL
Buresh	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Venzon	NULL
,	NULL
D.	NULL
,	NULL
Walker	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Fraker	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Strovroff	NULL
,	NULL
M.	NULL
C.	NULL
&	NULL
Norton	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88	NULL
,	NULL
34-39	NULL
.	NULL

19	NULL
.	NULL

Cross	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Sadoff	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Kelly	NULL
,	NULL
N.	NULL
,	NULL
Bernton	NULL
,	NULL
E.	NULL
&	NULL
Gemski	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

169	NULL
,	NULL
2021-2027	NULL
.	NULL

20	NULL
.	NULL

-	NULL
Nakane	NULL
,	NULL
A.	NULL
,	NULL
Minagawa	NULL
,	NULL
T.	NULL
&	NULL
Kato	NULL
,	NULL
K.	NULL
(	NULL
1988	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

56	NULL
,	NULL
2563-2569	NULL
.	NULL

21	NULL
.	NULL

Roll	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Young	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
Kurtz	NULL
,	NULL
R.	NULL
S.	NULL
&	NULL
Czuprynski	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Immunology	NULL
69	NULL
,	NULL
316-322	NULL
.	NULL

22	NULL
.	NULL

Beutler	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
625-656	NULL
.	NULL

23	NULL
.	NULL

Talmage	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Philips	NULL
,	NULL
H.	NULL
,	NULL
Scheider	NULL
,	NULL
M.	NULL
,	NULL
Rowe	NULL
,	NULL
T.	NULL
,	NULL
Pennington	NULL
,	NULL
R.	NULL
,	NULL
Brwersax	NULL
,	NULL
O	NULL
.	NULL

&	NULL
Lenz	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

48	NULL
,	NULL
544-553	NULL
.	NULL

24	NULL
.	NULL

Mathison	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Wolfson	NULL
,	NULL
E.	NULL
&	NULL
Ulevitch	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Inf	NULL
.	NULL

Dis	NULL
.	NULL

81	NULL
,	NULL
1925-1937	NULL
.	NULL

25	NULL
.	NULL

Tracey	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Fong	NULL
,	NULL
Y.	NULL
,	NULL
Hesse	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Manogue	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
Lee	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
Kuo	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
Lowry	NULL
,	NULL
S.	NULL
F.	NULL
&	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
330	NULL
,	NULL
662-664	NULL
.	NULL

26	NULL
.	NULL

Beutler	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Biochemistry	NULL
27	NULL
,	NULL
7575-7582	NULL
.	NULL

27	NULL
.	NULL

-	NULL
Neale	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Williams	NULL
,	NULL
B.	NULL
D.	NULL
&	NULL
Matthews	NULL
,	NULL
N.	NULL
(	NULL
1989	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Rheumatol	NULL
.	NULL

28	NULL
,	NULL
104-108	NULL
.	NULL

28	NULL
.	NULL

Manicourt	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Triki	NULL
,	NULL
R.	NULL
,	NULL
Fukuda	NULL
,	NULL
K.	NULL
,	NULL
Devogelaer	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Nagant	NULL
de	NULL
Deuxchaisnes	NULL
,	NULL
C.	NULL
&	NULL
Thonar	NULL
,	NULL
E.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Arthritis	NULL
Rheum	NULL
.	NULL

36	NULL
,	NULL
490-499	NULL
.	NULL

29	NULL
.	NULL

-	NULL
Duh	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
Maury	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
&	NULL
Rabson	NULL
,	NULL
A	NULL
.	NULL

B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
5974-5978	NULL
.	NULL

30	NULL
.	NULL

-	NULL
Osborn	NULL
,	NULL
L.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
&	NULL
Nabel	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
2336-2340	NULL
.	NULL

31	NULL
.	NULL

Popik	NULL
,	NULL
W.	NULL
&	NULL
Pitha	NULL
,	NULL
P.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

67	NULL
,	NULL
1094-1099	NULL
.	NULL

32	NULL
.	NULL

-	NULL
Vesanen	NULL
,	NULL
M.	NULL
,	NULL
Wessman	NULL
,	NULL
M.	NULL
,	NULL
Salminen	NULL
,	NULL
M.	NULL
&	NULL
Vaheri	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

73	NULL
,	NULL
1753-1760	NULL
.	NULL

33	NULL
.	NULL

Tracey	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Wei	NULL
,	NULL
H.	NULL
E.	NULL
&	NULL
Manogue	NULL
,	NULL
K.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167	NULL
,	NULL
1221-1227	NULL
.	NULL

34	NULL
.	NULL

-	NULL
Schleif	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
241	NULL
,	NULL
1182-1187	NULL
.	NULL

35	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Doyle	NULL
,	NULL
C.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
9769-9773.	NULL
a	NULL
sp	NULL
br	NULL
:	NULL
36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
4523	NULL
Vincenti	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
Burrel	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

&	NULL
Taffet	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Physiol	NULL
.	NULL

150	NULL
,	NULL
204-213	NULL
.	NULL

Drouet	NULL
,	NULL
C.	NULL
,	NULL
Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
&	NULL
Jongeneel	NULL
,	NULL
C.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
1694-1700	NULL
.	NULL

Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Vassalli	NULL
,	NULL
P.	NULL
,	NULL
Nedospasov	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

&	NULL
Jongeneel	NULL
,	NULL
C.	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
35-47	NULL
.	NULL

Taffet	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Singhel	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
Overholtzer	NULL
,	NULL
J.	NULL
F.	NULL
&	NULL
Shurtleff	NULL
,	NULL
S.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
.	NULL

Immunol	NULL
.	NULL

120	NULL
,	NULL
291-300	NULL
.	NULL

Sung	NULL
,	NULL
S.	NULL
S.	NULL
J.	NULL
,	NULL
Walters	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Hudson	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Gimble	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

147	NULL
,	NULL
2047-2054	NULL
.	NULL

Economou	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Rhoades	NULL
,	NULL
K.	NULL
,	NULL
Essner	NULL
,	NULL
R.	NULL
,	NULL
McBride	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
Gasson	NULL
,	NULL
J.	NULL
C.	NULL
&	NULL
Morton	NULL
,	NULL
D.	NULL
L.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170	NULL
,	NULL
321-326	NULL
.	NULL

Hensel	NULL
,	NULL
G.	NULL
,	NULL
Meiche	NULL
,	NULL
A.	NULL
,	NULL
Pfizenmaier	NULL
,	NULL
K.	NULL
&	NULL
Kronke	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Lymphokine	NULL
Res	NULL
.	NULL

8	NULL
,	NULL
347-351	NULL
.	NULL

Rhoades	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Golub	NULL
,	NULL
S.	NULL
H.	NULL
&	NULL
Economou	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
22102-22107	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Strominger	NULL
,	NULL
J.	NULL
L.	NULL
&	NULL
Doyle	NULL
,	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174	NULL
,	NULL
73-81	NULL
.	NULL

Leitman	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Mackow	NULL
,	NULL
E.	NULL
R.	NULL
,	NULL
Williams	NULL
,	NULL
T.	NULL
,	NULL
Baxter	NULL
,	NULL
J.	NULL
D.	NULL
&	NULL
West	NULL
,	NULL
B.	NULL
L.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
1352-1356	NULL
.	NULL

Nedospasov	NULL
,	NULL
A.	NULL
,	NULL
Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Turetskaya	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Mett	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
Azizov	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
Georgiev	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
Korobko	NULL
,	NULL
V.	NULL
G.	NULL
,	NULL
Dobrynin	NULL
,	NULL
V.	NULL
N.	NULL
,	NULL
Filippov	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Bystrov	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

551	NULL
,	NULL
611-624	NULL
.	NULL

Nedwin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Nayler	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Sakaguchi	NULL
,	NULL
A.	NULL
Y.	NULL
,	NULL
Smith	NULL
,	NULL
D.	NULL
,	NULL
Jarrett-Nedwin	NULL
,	NULL
J.	NULL
,	NULL
Pennica	NULL
,	NULL
D.	NULL
,	NULL
Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
&	NULL
Gray	NULL
,	NULL
P.	NULL
(	NULL
1985	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

13	NULL
,	NULL
6361-6373	NULL
.	NULL

Cordle	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Donald	NULL
,	NULL
R.	NULL
,	NULL
Read	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

&	NULL
Hawiger	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
11803-11810	NULL
.	NULL

Miiller	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Loms	NULL
Ziegler-Hettbrock	NULL
,	NULL
H.	NULL
W.	NULL
&	NULL
Bacuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Immunobiology	NULL
187	NULL
,	NULL
233-256	NULL
.	NULL

Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Berlin	NULL
,	NULL
D.	NULL
,	NULL
Vassalli	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Dekossodo	NULL
,	NULL
S.	NULL
&	NULL
Vassalli	NULL
,	NULL
P.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

164	NULL
,	NULL
2113-2118	NULL
.	NULL

Shakhov	NULL
,	NULL
A.	NULL
N.	NULL
,	NULL
Collart	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Vassalli	NULL
,	NULL
P.	NULL
,	NULL
Nedospasov	NULL
,	NULL
S.	NULL
V.	NULL
&	NULL
Jongeneel	NULL
,	NULL
C.	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
35-47	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Doyle	NULL
,	NULL
C.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
9769-9773	NULL
.	NULL

Takashiba	NULL
,	NULL
S.	NULL
,	NULL
Van	NULL
Dyke	NULL
,	NULL
T.	NULL
E.	NULL
,	NULL
Shapira	NULL
,	NULL
L.	NULL
&	NULL
Amar	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

63	NULL
,	NULL
1529-1534	NULL
.	NULL

Shapira	NULL
,	NULL
L.	NULL
,	NULL
Takashiba	NULL
,	NULL
S.	NULL
,	NULL
Amar	NULL
,	NULL
S.	NULL
&	NULL
Van	NULL
Dyke	NULL
,	NULL
T.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Oral	NULL
Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

9	NULL
,	NULL
112-117	NULL
.	NULL

Takashiba	NULL
,	NULL
S.	NULL
,	NULL
Shapira	NULL
,	NULL
L.	NULL
,	NULL
Amar	NULL
,	NULL
S.	NULL
&	NULL
Van	NULL
Dyke	NULL
,	NULL
T.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Gene	NULL
131	NULL
,	NULL
307-308	NULL
.	NULL

Gabrielsen	NULL
,	NULL
O.	NULL
S.	NULL
&	NULL
Huet	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Methods	NULL
Enzymol	NULL
.	NULL

218	NULL
,	NULL
508-525	NULL
.	NULL

Matsudaira	NULL
,	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
10035-10038	NULL
.	NULL

Fernandez	NULL
,	NULL
J.	NULL
,	NULL
DeMott	NULL
,	NULL
M.	NULL
,	NULL
Atherton	NULL
,	NULL
D.	NULL
&	NULL
Mische	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

201	NULL
,	NULL
255-264	NULL
.	NULL

Ausubel	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Brent	NULL
,	NULL
R.	NULL
,	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Seidman	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Smith	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Struhl	NULL
,	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
in	NULL
Short	NULL
Protocols	NULL
in	NULL
Molecular	NULL
Biology	NULL
(	NULL
Greene	NULL
&	NULL
Wiley	NULL
,	NULL
New	NULL
York	NULL
)	NULL
,	NULL
3rd	NULL
Ed	NULL
.	NULL

Maret	NULL
,	NULL
A.	NULL
,	NULL
Galy	NULL
,	NULL
B.	NULL
,	NULL
Arnaud	NULL
,	NULL
E.	NULL
,	NULL
Bayard	NULL
,	NULL
F.	NULL
&	NULL
Prats	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

55	NULL
,	NULL
5075-5079	NULL
.	NULL

Boshart	NULL
,	NULL
M.	NULL
,	NULL
Weber	NULL
,	NULL
F.	NULL
,	NULL
Jahn	NULL
,	NULL
G.	NULL
,	NULL
Dorsch-Hasler	NULL
,	NULL
K.	NULL
,	NULL
Fleckenstein	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
41	NULL
,	NULL
521-530	NULL
.	NULL

Polyak	NULL
,	NULL
K.	NULL
,	NULL
Xia	NULL
,	NULL
Y.	NULL
,	NULL
Zweier	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Kinzler	NULL
,	NULL
K.	NULL
W.	NULL
&	NULL
Vogelstein	NULL
,	NULL
B	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
18	NULL
,	NULL
300-305	NULL
.	NULL

Mahone	NULL
,	NULL
M.	NULL
,	NULL
Saffman	NULL
,	NULL
E.	NULL
E.	NULL
&	NULL
Lasko	NULL
,	NULL
P.	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
2043-2055	NULL
.	NULL

Neuenchwander	NULL
,	NULL
S.	NULL
,	NULL
Roberts	NULL
,	NULL
C.	NULL
T.	NULL
&	NULL
LeRoith	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Endocrinology	NULL
136	NULL
,	NULL
4298-4303	NULL
.	NULL

Stein	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Antisense	NULL
Nucleic	NULL
Acid	NULL
Drug	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
129-132	NULL
.	NULL

Helene	NULL
,	NULL
C.	NULL
,	NULL
Giovannangeli	NULL
,	NULL
C.	NULL
&	NULL
Guieysse-Peugeot	NULL
,	NULL
A.	NULL
L.	NULL
(	NULL
1997	NULL
)	NULL
CIBA	NULL
Found	NULL
.	NULL

Symp	NULL
.	NULL

209	NULL
,	NULL
94-102	NULL
.	NULL

Morales	NULL
,	NULL
A.	NULL
V.	NULL
,	NULL
de	NULL
Pablo	NULL
,	NULL
F.	NULL
(	NULL
1998	NULL
)	NULL
Curr	NULL
.	NULL

Topics	NULL
Dev	NULL
.	NULL

Biol	NULL
.	NULL

36	NULL
,	NULL
37-49	NULL
.	NULL

Agrawal	NULL
,	NULL
S.	NULL
&	NULL
Iyer	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1997	NULL
)	NULL
Pharmacol	NULL
.	NULL

Ther	NULL
.	NULL

76	NULL
,	NULL
151-60	NULL
.	NULL

Kim	NULL
,	NULL
S.	NULL
K.	NULL
&	NULL
Wold	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cell	NULL
42	NULL
,	NULL
129-138	NULL
.	NULL

Crooke	NULL
S.	NULL
T.	NULL
&	NULL
Lebleu	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Antisense	NULL
Research	NULL
and	NULL
Therapeutic	NULL
(	NULL
CRC	NULL
,	NULL
Boca	NULL
Raton	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Bennett	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Condon	NULL
,	NULL
T.	NULL
P.	NULL
,	NULL
Grimm	NULL
,	NULL
S.	NULL
,	NULL
Chan	NULL
,	NULL
H.	NULL
&	NULL
Chiang	NULL
,	NULL
M.	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
3530-3540	NULL
.	NULL

Dean	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
McKay	NULL
,	NULL
R.	NULL
&	NULL
Condon	NULL
,	NULL
T.	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
16416-16124	NULL
.	NULL

Perlaky	NULL
,	NULL
L.	NULL
,	NULL
Saijo	NULL
,	NULL
Y.	NULL
,	NULL
Busch	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Bennett	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Mirabelli	NULL
,	NULL
C.	NULL
K.	NULL
&	NULL
Crooke	NULL
,	NULL
S.	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Anti-Cancer	NULL
Drug	NULL
Design	NULL
.	NULL

8	NULL
,	NULL
3-14	NULL
.	NULL

Chiang	NULL
,	NULL
M.	NULL
Y.	NULL
,	NULL
Chan	NULL
,	NULL
H.	NULL
,	NULL
Zounes	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Freier	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Lima	NULL
,	NULL
W.	NULL
F.	NULL
&	NULL
Bennett	NULL
,	NULL
C.	NULL
F.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
18162-18171	NULL
.	NULL

Yao	NULL
,	NULL
J.	NULL
,	NULL
Mackman	NULL
,	NULL
N.	NULL
,	NULL
Edgington	NULL
,	NULL
T.	NULL
S.	NULL
&	NULL
Fan	NULL
,	NULL
S.	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
17795-17801	NULL
.	NULL

Giroir	NULL
,	NULL
B.	NULL
P.	NULL
,	NULL
Johnson	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Brown	NULL
,	NULL
T.	NULL
,	NULL
Allen	NULL
,	NULL
G.	NULL
L.	NULL
&	NULL
Beutler	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90	NULL
,	NULL
693-698	NULL
.	NULL

Ruco	NULL
,	NULL
L.	NULL
P.	NULL
,	NULL
Stoppacciaro	NULL
,	NULL
A.	NULL
,	NULL
Pomponi	NULL
,	NULL
D.	NULL
,	NULL
Boraschi	NULL
,	NULL
D.	NULL
,	NULL
Santoni	NULL
,	NULL
A.	NULL
,	NULL
Tagliabue	NULL
,	NULL
A.	NULL
,	NULL
Uccini	NULL
,	NULL
S.	NULL
&	NULL
Baroni	NULL
,	NULL
C.	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

135	NULL
,	NULL
889-897	NULL
.	NULL

Carson	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

&	NULL
Lois	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Lancet	NULL
346	NULL
,	NULL
1009-1011	NULL
.	NULL

Sherr	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Science	NULL
274	NULL
,	NULL
1672-1677	NULL
.	NULL

Brune	NULL
,	NULL
B.	NULL
,	NULL
Gotz	NULL
,	NULL
C.	NULL
,	NULL
Messmer	NULL
,	NULL
U.	NULL
K.	NULL
,	NULL
Sandau	NULL
,	NULL
K.	NULL
,	NULL
Hirvonen	NULL
,	NULL
M.	NULL
R.	NULL
&	NULL
Lapetina	NULL
,	NULL
E.	NULL
G.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
7253-7258	NULL
.	NULL

Shapira	NULL
,	NULL
L.	NULL
,	NULL
Champagne	NULL
,	NULL
C.	NULL
,	NULL
Van	NULL
Dyke	NULL
,	NULL
T.	NULL
E.	NULL
&	NULL
Amar	NULL
,	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
Infect	NULL
.	NULL

Immun	NULL
.	NULL

66	NULL
,	NULL
2736-2742	NULL
.	NULL

Margulies	NULL
,	NULL
L.	NULL
&	NULL
Sehgal	NULL
,	NULL
P.	NULL
B	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
15096-15100	NULL
.	NULL

Pesch	NULL
,	NULL
J.	NULL
,	NULL
Brehm	NULL
,	NULL
U.	NULL
,	NULL
Staib	NULL
,	NULL
C.	NULL
&	NULL
Grummt	NULL
,	NULL
F.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Interferon	NULL
Cytokine	NULL
Res	NULL
.	NULL

16	NULL
,	NULL
595-600	NULL
.	NULL

Claverie	NULL
,	NULL
J.-M.	NULL
&	NULL
Makalowski	NULL
,	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
371	NULL
,	NULL
752	NULL
.	NULL

